BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Garcia-Olmo D, Herreros D, Pascual I, Pascual JA, Del-Valle E, Zorrilla J, De-La-Quintana P, Garcia-Arranz M, Pascual M. Expanded adipose-derived stem cells for the treatment of complex perianal fistula: a phase II clinical trial. Dis Colon Rectum. 2009;52:79-86. [PMID: 19273960 DOI: 10.1007/dcr.0b013e3181973487] [Cited by in Crossref: 539] [Cited by in F6Publishing: 219] [Article Influence: 41.5] [Reference Citation Analysis]
Number Citing Articles
1 Manieri NA, Stappenbeck TS. Mesenchymal stem cell therapy of intestinal disease: are their effects systemic or localized? Curr Opin Gastroenterol 2011;27:119-24. [PMID: 21150589 DOI: 10.1097/MOG.0b013e3283423f20] [Cited by in Crossref: 16] [Cited by in F6Publishing: 7] [Article Influence: 1.5] [Reference Citation Analysis]
2 Cao Y, Ding Z, Han C, Shi H, Cui L, Lin R. Efficacy of Mesenchymal Stromal Cells for Fistula Treatment of Crohn's Disease: A Systematic Review and Meta-Analysis. Dig Dis Sci 2017;62:851-60. [PMID: 28168575 DOI: 10.1007/s10620-017-4453-x] [Cited by in Crossref: 22] [Cited by in F6Publishing: 24] [Article Influence: 4.4] [Reference Citation Analysis]
3 Sarnik SA, Sutermaster BA, Darling EM. Mass-Added Density Modulation for Sorting Cells Based on Differential Surface Protein Levels. Cytometry A 2021;99:488-95. [PMID: 32687243 DOI: 10.1002/cyto.a.24192] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
4 Tran TT, Kahn CR. Transplantation of adipose tissue and stem cells: role in metabolism and disease. Nat Rev Endocrinol 2010;6:195-213. [PMID: 20195269 DOI: 10.1038/nrendo.2010.20] [Cited by in Crossref: 207] [Cited by in F6Publishing: 192] [Article Influence: 17.3] [Reference Citation Analysis]
5 Kim RH, Mehrazarin S, Kang MK. Therapeutic potential of mesenchymal stem cells for oral and systemic diseases. Dent Clin North Am 2012;56:651-75. [PMID: 22835544 DOI: 10.1016/j.cden.2012.05.006] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 1.7] [Reference Citation Analysis]
6 Huang H, Ji L, Gu Y, Li Y, Xu S. Efficacy and Safety of Sphincter-Preserving Surgery in the Treatment of Complex Anal Fistula: A Network Meta-Analysis. Front Surg 2022;9:825166. [DOI: 10.3389/fsurg.2022.825166] [Reference Citation Analysis]
7 Eberspacher C, Mascagni D, Ferent IC, Coletta E, Palma R, Panetta C, Esposito A, Arcieri S, Pontone S. Mesenchymal Stem Cells for Cryptoglandular Anal Fistula: Current State of Art. Front Surg 2022;9:815504. [DOI: 10.3389/fsurg.2022.815504] [Reference Citation Analysis]
8 Voswinkel J, Francois S, Gorin NC, Chapel A. Gastro-intestinal autoimmunity: preclinical experiences and successful therapy of fistulizing bowel diseases and gut Graft versus host disease by mesenchymal stromal cells. Immunol Res 2013;56:241-8. [PMID: 23564182 DOI: 10.1007/s12026-013-8397-8] [Cited by in Crossref: 22] [Cited by in F6Publishing: 21] [Article Influence: 2.8] [Reference Citation Analysis]
9 Park MY, Yoon YS, Lee JL, Park SH, Ye BD, Yang SK, Yu CS. Comparative perianal fistula closure rates following autologous adipose tissue-derived stem cell transplantation or treatment with anti-tumor necrosis factor agents after seton placement in patients with Crohn's disease: a retrospective observational study. Stem Cell Res Ther 2021;12:401. [PMID: 34256838 DOI: 10.1186/s13287-021-02484-6] [Reference Citation Analysis]
10 Kuhbier JW, Weyand B, Sorg H, Radtke C, Vogt PM, Reimers K. [Stem cells from fatty tissue : A new resource for regenerative medicine? Chirurg. 2010;81:826-832. [PMID: 20830547 DOI: 10.1007/s00104-010-1962-y] [Cited by in Crossref: 23] [Cited by in F6Publishing: 19] [Article Influence: 2.1] [Reference Citation Analysis]
11 Guo X, Yu R, Xu Y, Lian R, Yu Y, Cui Z, Ji Q, Chen J, Li Z, Liu H, Chen J. PAC1R agonist maxadilan enhances hADSC viability and neural differentiation potential. J Cell Mol Med 2016;20:874-90. [PMID: 26798992 DOI: 10.1111/jcmm.12772] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 1.5] [Reference Citation Analysis]
12 Laureti S, Gionchetti P, Cappelli A, Vittori L, Contedini F, Rizzello F, Golfieri R, Campieri M, Poggioli G. Refractory Complex Crohn's Perianal Fistulas: A Role for Autologous Microfragmented Adipose Tissue Injection. Inflamm Bowel Dis 2020;26:321-30. [PMID: 31220252 DOI: 10.1093/ibd/izz051] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 6.0] [Reference Citation Analysis]
13 Wong RS. Mesenchymal stem cells: angels or demons? J Biomed Biotechnol. 2011;2011:459510. [PMID: 21822372 DOI: 10.1155/2011/459510] [Cited by in Crossref: 59] [Cited by in F6Publishing: 67] [Article Influence: 5.4] [Reference Citation Analysis]
14 Trébol J, Carabias-Orgaz A, García-Arranz M, García-Olmo D. Stem cell therapy for faecal incontinence: Current state and future perspectives. World J Stem Cells 2018; 10(7): 82-105 [PMID: 30079130 DOI: 10.4252/wjsc.v10.i7.82] [Cited by in Crossref: 9] [Cited by in F6Publishing: 5] [Article Influence: 2.3] [Reference Citation Analysis]
15 Kuhbier JW, Reimers K, Radtke C, Vogt PM. [Regenerative therapy approaches in plastic surgery]. Chirurg 2015;86:214-22. [PMID: 25709000 DOI: 10.1007/s00104-014-2830-y] [Cited by in Crossref: 2] [Article Influence: 0.3] [Reference Citation Analysis]
16 Buscail E, Le Cosquer G, Gross F, Lebrin M, Bugarel L, Deraison C, Vergnolle N, Bournet B, Gilletta C, Buscail L. Adipose-Derived Stem Cells in the Treatment of Perianal Fistulas in Crohn's Disease: Rationale, Clinical Results and Perspectives. Int J Mol Sci 2021;22:9967. [PMID: 34576129 DOI: 10.3390/ijms22189967] [Reference Citation Analysis]
17 Gimble JM, Guilak F, Bunnell BA. Clinical and preclinical translation of cell-based therapies using adipose tissue-derived cells. Stem Cell Res Ther. 2010;1:19. [PMID: 20587076 DOI: 10.1186/scrt19] [Cited by in Crossref: 181] [Cited by in F6Publishing: 165] [Article Influence: 15.1] [Reference Citation Analysis]
18 Voswinkel J, Francois S, Simon JM, Benderitter M, Gorin NC, Mohty M, Fouillard L, Chapel A. Use of mesenchymal stem cells (MSC) in chronic inflammatory fistulizing and fibrotic diseases: a comprehensive review. Clin Rev Allergy Immunol 2013;45:180-92. [PMID: 23296948 DOI: 10.1007/s12016-012-8347-6] [Reference Citation Analysis]
19 Marzo M, Felice C, Pugliese D, Andrisani G, Mocci G, Armuzzi A, Guidi L. Management of perianal fistulas in Crohn’s disease: An up-to-date review. World J Gastroenterol 2015; 21(5): 1394-1403 [PMID: 25663759 DOI: 10.3748/wjg.v21.i5.1394] [Cited by in CrossRef: 45] [Cited by in F6Publishing: 34] [Article Influence: 6.4] [Reference Citation Analysis]
20 Utsunomiya T, Shimada M, Imura S, Morine Y, Ikemoto T, Mori H, Hanaoka J, Iwahashi S, Saito Y, Iwaguro H. Human adipose-derived stem cells: potential clinical applications in surgery. Surg Today 2011;41:18-23. [PMID: 21191687 DOI: 10.1007/s00595-010-4415-9] [Cited by in Crossref: 34] [Cited by in F6Publishing: 27] [Article Influence: 2.8] [Reference Citation Analysis]
21 Cao Y, Su Q, Zhang B, Shen F, Li S. Efficacy of stem cells therapy for Crohn's fistula: a meta-analysis and systematic review. Stem Cell Res Ther 2021;12:32. [PMID: 33413661 DOI: 10.1186/s13287-020-02095-7] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 4.0] [Reference Citation Analysis]
22 Cantu DA, Kao WJ. Combinatorial biomatrix/cell-based therapies for restoration of host tissue architecture and function. Adv Healthc Mater 2013;2:1544-63. [PMID: 23828863 DOI: 10.1002/adhm.201300063] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 1.3] [Reference Citation Analysis]
23 Ciccocioppo R, Cangemi GC, Kruzliak P, Gallia A, Betti E, Badulli C, Martinetti M, Cervio M, Pecci A, Bozzi V, Dionigi P, Visai L, Gurrado A, Alvisi C, Picone C, Monti M, Bernardo ME, Gobbi P, Corazza GR. Ex vivo immunosuppressive effects of mesenchymal stem cells on Crohn's disease mucosal T cells are largely dependent on indoleamine 2,3-dioxygenase activity and cell-cell contact. Stem Cell Res Ther 2015;6:137. [PMID: 26206376 DOI: 10.1186/s13287-015-0122-1] [Cited by in Crossref: 36] [Cited by in F6Publishing: 36] [Article Influence: 5.1] [Reference Citation Analysis]
24 Beksac K, Tanacan A, Ozgul N, Beksac MS. Treatment of Rectovaginal Fistula Using Sphincteroplasty and Fistulectomy. Obstet Gynecol Int 2018;2018:5298214. [PMID: 29853904 DOI: 10.1155/2018/5298214] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
25 Scharl M, Rogler G, Biedermann L. Fistulizing Crohn's Disease. Clin Transl Gastroenterol. 2017;8:e106. [PMID: 28703786 DOI: 10.1038/ctg.2017.33] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 3.0] [Reference Citation Analysis]
26 Sahnan K, Tozer PJ, Adegbola SO, Lee MJ, Heywood N, McNair AGK, Hind D, Yassin N, Lobo AJ, Brown SR, Sebastian S, Phillips RKS, Lung PFC, Faiz OD, Crook K, Blackwell S, Verjee A, Hart AL, Fearnhead NS;  ENiGMA collaborators. Developing a core outcome set for fistulising perianal Crohn's disease. Gut. 2019;68:226-238. [PMID: 29437911 DOI: 10.1136/gutjnl-2017-315503] [Cited by in Crossref: 31] [Cited by in F6Publishing: 32] [Article Influence: 7.8] [Reference Citation Analysis]
27 Park EJ, Kang J, Baik SH. Treatment of faecal incontinence using allogeneic-adipose-derived mesenchymal stem cells: a study protocol for a pilot randomised controlled trial. BMJ Open. 2016;6:e010450. [PMID: 26888731 DOI: 10.1136/bmjopen-2015-010450] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 1.5] [Reference Citation Analysis]
28 Sémont A, Demarquay C, Bessout R, Durand C, Benderitter M, Mathieu N. Mesenchymal stem cell therapy stimulates endogenous host progenitor cells to improve colonic epithelial regeneration. PLoS One. 2013;8:e70170. [PMID: 23922953 DOI: 10.1371/journal.pone.0070170] [Cited by in Crossref: 46] [Cited by in F6Publishing: 47] [Article Influence: 5.1] [Reference Citation Analysis]
29 Lu S, Zhu K, Guo Y, Wang E, Huang J. Evaluation of animal models of Crohn's disease with anal fistula (Review). Exp Ther Med 2021;22:974. [PMID: 34335916 DOI: 10.3892/etm.2021.10406] [Reference Citation Analysis]
30 Schneider N, Gonçalves Fda C, Pinto FO, Lopez PL, Araújo AB, Pfaffenseller B, Passos EP, Cirne-Lima EO, Meurer L, Lamers ML, Paz AH. Dexamethasone and azathioprine promote cytoskeletal changes and affect mesenchymal stem cell migratory behavior. PLoS One 2015;10:e0120538. [PMID: 25756665 DOI: 10.1371/journal.pone.0120538] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 2.1] [Reference Citation Analysis]
31 Qin X, Wang P, Huang Y, Li Y, Chao M, Wang W. Adipose-Derived Stem Cells Are an Efficient Treatment for Fistula-in-ano of Japanese Rabbit. Stem Cells Int 2019;2019:6918090. [PMID: 31781244 DOI: 10.1155/2019/6918090] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
32 DelaRosa O, Sánchez-Correa B, Morgado S, Ramírez C, del Río B, Menta R, Lombardo E, Tarazona R, Casado JG. Human adipose-derived stem cells impair natural killer cell function and exhibit low susceptibility to natural killer-mediated lysis. Stem Cells Dev. 2012;21:1333-1343. [PMID: 21867426 DOI: 10.1089/scd.2011.0139] [Cited by in Crossref: 57] [Cited by in F6Publishing: 61] [Article Influence: 5.2] [Reference Citation Analysis]
33 Ocansey DKW, Qiu W, Wang J, Yan Y, Qian H, Zhang X, Xu W, Mao F. The Achievements and Challenges of Mesenchymal Stem Cell-Based Therapy in Inflammatory Bowel Disease and Its Associated Colorectal Cancer. Stem Cells Int 2020;2020:7819824. [PMID: 32256612 DOI: 10.1155/2020/7819824] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 5.5] [Reference Citation Analysis]
34 Choi S, Ryoo SB, Park KJ, Kim DS, Song KH, Kim KH, Chung SS, Shin EJ, Cho YB, Oh ST, Kang WK, Kim MH. Autologous adipose tissue-derived stem cells for the treatment of complex perianal fistulas not associated with Crohn's disease: a phase II clinical trial for safety and efficacy. Tech Coloproctol 2017;21:345-53. [PMID: 28567691 DOI: 10.1007/s10151-017-1630-z] [Cited by in Crossref: 18] [Cited by in F6Publishing: 14] [Article Influence: 3.6] [Reference Citation Analysis]
35 Panes J, Reinisch W, Rupniewska E, Khan S, Forns J, Khalid JM, Bojic D, Patel H. Burden and outcomes for complex perianal fistulas in Crohn’s disease: Systematic review. World J Gastroenterol 2018; 24(42): 4821-4834 [PMID: 30479468 DOI: 10.3748/wjg.v24.i42.4821] [Cited by in CrossRef: 21] [Cited by in F6Publishing: 13] [Article Influence: 5.3] [Reference Citation Analysis]
36 Cadeddu F, Salis F, Lisi G, Ciangola I, Milito G. Complex anal fistula remains a challenge for colorectal surgeon. Int J Colorectal Dis 2015;30:595-603. [PMID: 25566951 DOI: 10.1007/s00384-014-2104-7] [Cited by in Crossref: 24] [Cited by in F6Publishing: 15] [Article Influence: 3.4] [Reference Citation Analysis]
37 Feisst V, Meidinger S, Locke MB. From bench to bedside: use of human adipose-derived stem cells. Stem Cells Cloning. 2015;8:149-162. [PMID: 26586955 DOI: 10.2147/sccaa.s64373] [Cited by in Crossref: 16] [Cited by in F6Publishing: 34] [Article Influence: 2.3] [Reference Citation Analysis]
38 Carvello M, Lightner A, Yamamoto T, Kotze PG, Spinelli A. Mesenchymal Stem Cells for Perianal Crohn's Disease. Cells. 2019;8. [PMID: 31340546 DOI: 10.3390/cells8070764] [Cited by in Crossref: 22] [Cited by in F6Publishing: 21] [Article Influence: 7.3] [Reference Citation Analysis]
39 Hossein-Khannazer N, Torabi S, Hosseinzadeh R, Shahrokh S, Asadzadeh Aghdaei H, Memarnejadian A, Kadri N, Vosough M. Novel cell-based therapies in inflammatory bowel diseases: the established concept, promising results. Hum Cell 2021;34:1289-300. [PMID: 34057700 DOI: 10.1007/s13577-021-00560-w] [Reference Citation Analysis]
40 Park SH, Aniwan S, Scott Harmsen W, Tremaine WJ, Lightner AL, Faubion WA, Loftus EV. Update on the Natural Course of Fistulizing Perianal Crohn's Disease in a Population-Based Cohort. Inflamm Bowel Dis. 2019;25:1054-1060. [PMID: 30346531 DOI: 10.1093/ibd/izy329] [Cited by in Crossref: 29] [Cited by in F6Publishing: 25] [Article Influence: 14.5] [Reference Citation Analysis]
41 Dorronsoro A, Fernández-Rueda J, Fechter K, Ferrin I, Salcedo JM, Jakobsson E, Trigueros C. Human mesenchymal stromal cell-mediated immunoregulation: mechanisms of action and clinical applications. Bone Marrow Res. 2013;2013:203643. [PMID: 24187625 DOI: 10.1155/2013/203643] [Cited by in Crossref: 27] [Cited by in F6Publishing: 26] [Article Influence: 3.0] [Reference Citation Analysis]
42 Cirocchi R, Trastulli S, Morelli U, Desiderio J, Boselli C, Parisi A, Noya G. The treatment of anal fistulas with biologically derived products: is innovation better than conventional surgical treatment? An update. Tech Coloproctol 2013;17:259-73. [PMID: 23207714 DOI: 10.1007/s10151-012-0948-9] [Cited by in Crossref: 21] [Cited by in F6Publishing: 13] [Article Influence: 2.1] [Reference Citation Analysis]
43 Fabiani B, Menconi C, Martellucci J, Giani I, Toniolo G, Naldini G. Permacol™ collagen paste injection for the treatment of complex anal fistula: 1-year follow-up. Tech Coloproctol 2017;21:211-5. [PMID: 28210857 DOI: 10.1007/s10151-017-1590-3] [Cited by in Crossref: 13] [Cited by in F6Publishing: 10] [Article Influence: 2.6] [Reference Citation Analysis]
44 Turse EP, Dailey FE, Naseer M, Partyka EK, Bragg JD, Tahan V. Stem cells for luminal, fistulizing, and perianal inflammatory bowel disease: a comprehensive updated review of the literature. Stem Cells Cloning 2018;11:95-113. [PMID: 30568468 DOI: 10.2147/SCCAA.S135414] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
45 Abumaree M, Al Jumah M, Pace RA, Kalionis B. Immunosuppressive properties of mesenchymal stem cells. Stem Cell Rev Rep. 2012;8:375-392. [PMID: 21892603 DOI: 10.1007/s12015-011-9312-0] [Cited by in Crossref: 161] [Cited by in F6Publishing: 161] [Article Influence: 16.1] [Reference Citation Analysis]
46 Li Z, Mu D, Liu C, Xin M, Fu S, Li S, Qi J, Cheng H, Wang C, Wang Q, Luan J. The Impact of Ammonium Chloride-Based Erythrocyte Lysis Process on Banked Adipose-Derived Stem Cells. Biopreserv Biobank 2021. [PMID: 34704812 DOI: 10.1089/bio.2021.0035] [Reference Citation Analysis]
47 Garcia-Arranz M, Garcia-Olmo D, Herreros MD, Gracia-Solana J, Guadalajara H, de la Portilla F, Baixauli J, Garcia-Garcia J, Ramirez JM, Sanchez-Guijo F, Prosper F;  FISPAC Collaborative Group. Autologous adipose-derived stem cells for the treatment of complex cryptoglandular perianal fistula: A randomized clinical trial with long-term follow-up. Stem Cells Transl Med. 2020;9:295-301. [PMID: 31886629 DOI: 10.1002/sctm.19-0271] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 4.0] [Reference Citation Analysis]
48 Gecse K, Khanna R, Stoker J, Jenkins JT, Gabe S, Hahnloser D, D'Haens G. Fistulizing Crohn's disease: Diagnosis and management. United European Gastroenterol J. 2013;1:206-213. [PMID: 24917961 DOI: 10.1177/2050640613487194] [Cited by in Crossref: 26] [Cited by in F6Publishing: 17] [Article Influence: 3.3] [Reference Citation Analysis]
49 Romano B, Lleo A, Sala E, D’amico G, Marino DI, Ciccocioppo R, Vetrano S. Mesenchymal Stem Cells to Treat Digestive System Disorders: Progress Made and Future Directions. Curr Transpl Rep 2019;6:134-45. [DOI: 10.1007/s40472-019-00238-1] [Reference Citation Analysis]
50 Shawki S, Wexner SD. Idiopathic fistula-in-ano. World J Gastroenterol 2011; 17(28): 3277-3285 [PMID: 21876614 DOI: 10.3748/wjg.v17.i28.3277] [Cited by in CrossRef: 25] [Cited by in F6Publishing: 17] [Article Influence: 2.3] [Reference Citation Analysis]
51 Inyang KE, Folger JK, Laumet G. Can FDA-Approved Immunomodulatory Drugs be Repurposed/Repositioned to Alleviate Chronic Pain? J Neuroimmune Pharmacol 2021;16:531-47. [PMID: 34041656 DOI: 10.1007/s11481-021-10000-z] [Reference Citation Analysis]
52 Ommer A, Herold A, Berg E, Farke S, Fürst A, Hetzer F, Köhler A, Post S, Ruppert R, Sailer M, Schiedeck T, Schwandner O, Strittmatter B, Lenhard BH, Bader W, Krege S, Krammer H, Stange E. S3-Leitlinie: Kryptoglanduläre Analfisteln: 2. revidierte Fassung, AWMF‑Registriernummer: 088/003. coloproctology 2017;39:16-66. [DOI: 10.1007/s00053-016-0110-7] [Cited by in Crossref: 25] [Cited by in F6Publishing: 3] [Article Influence: 4.2] [Reference Citation Analysis]
53 Lin G, Wang G, Banie L, Ning H, Shindel AW, Fandel TM, Lue TF, Lin CS. Treatment of stress urinary incontinence with adipose tissue-derived stem cells. Cytotherapy. 2010;12:88-95. [PMID: 19878076 DOI: 10.3109/14653240903350265] [Cited by in Crossref: 141] [Cited by in F6Publishing: 123] [Article Influence: 11.8] [Reference Citation Analysis]
54 Forte D, Ciciarello M, Valerii MC, De Fazio L, Cavazza E, Giordano R, Parazzi V, Lazzari L, Laureti S, Rizzello F, Cavo M, Curti A, Lemoli RM, Spisni E, Catani L. Human cord blood-derived platelet lysate enhances the therapeutic activity of adipose-derived mesenchymal stromal cells isolated from Crohn's disease patients in a mouse model of colitis. Stem Cell Res Ther 2015;6:170. [PMID: 26353774 DOI: 10.1186/s13287-015-0166-2] [Cited by in Crossref: 19] [Cited by in F6Publishing: 17] [Article Influence: 2.7] [Reference Citation Analysis]
55 Ommer A, Herold A, Berg E, Fürst A, Post S, Ruppert R, Schiedeck T, Schwandner O, Strittmatter B. German S3 guidelines: anal abscess and fistula (second revised version). Langenbecks Arch Surg 2017;402:191-201. [PMID: 28251361 DOI: 10.1007/s00423-017-1563-z] [Cited by in Crossref: 40] [Cited by in F6Publishing: 19] [Article Influence: 8.0] [Reference Citation Analysis]
56 Scoglio D, Walker AS, Fichera A. Biomaterials in the treatment of anal fistula: hope or hype? Clin Colon Rectal Surg 2014;27:172-81. [PMID: 25435826 DOI: 10.1055/s-0034-1394156] [Cited by in Crossref: 11] [Cited by in F6Publishing: 7] [Article Influence: 1.4] [Reference Citation Analysis]
57 de la Portilla F, Alba F, García-olmo D, Herrerías JM, González FX, Galindo A. Expanded allogeneic adipose-derived stem cells (eASCs) for the treatment of complex perianal fistula in Crohn’s disease: results from a multicenter phase I/IIa clinical trial. Int J Colorectal Dis 2013;28:313-23. [DOI: 10.1007/s00384-012-1581-9] [Cited by in Crossref: 215] [Cited by in F6Publishing: 190] [Article Influence: 21.5] [Reference Citation Analysis]
58 Garcia-Olmo D, Guadalajara H, Rubio-Perez I, Herreros MD, de-la-Quintana P, Garcia-Arranz M. Recurrent anal fistulae: Limited surgery supported by stem cells. World J Gastroenterol 2015; 21(11): 3330-3336 [PMID: 25805941 DOI: 10.3748/wjg.v21.i11.3330] [Cited by in CrossRef: 38] [Cited by in F6Publishing: 29] [Article Influence: 5.4] [Reference Citation Analysis]
59 Ntege EH, Sunami H, Shimizu Y. Advances in regenerative therapy: A review of the literature and future directions. Regen Ther 2020;14:136-53. [PMID: 32110683 DOI: 10.1016/j.reth.2020.01.004] [Cited by in Crossref: 20] [Cited by in F6Publishing: 20] [Article Influence: 10.0] [Reference Citation Analysis]
60 Molendijk I, Duijvestein M, van der Meulen-de Jong AE, van Deen WK, Swets M, Hommes DW, Verspaget HW. Immunomodulatory effects of mesenchymal stromal cells in Crohn's disease. J Allergy (Cairo) 2012;2012:187408. [PMID: 23049573 DOI: 10.1155/2012/187408] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 0.5] [Reference Citation Analysis]
61 Nikolic M, Stift A, Reinisch W, Vogelsang H, Matic A, Müller C, von Strauss Und Torney M, Riss S. Allogeneic expanded adipose-derived stem cells in the treatment of rectovaginal fistulas in Crohn's disease. Colorectal Dis 2021;23:153-8. [PMID: 32810356 DOI: 10.1111/codi.15324] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
62 Wiese DM, Schwartz DA. Managing Perianal Crohn’s Disease. Curr Gastroenterol Rep 2012;14:153-61. [DOI: 10.1007/s11894-012-0243-y] [Cited by in Crossref: 16] [Cited by in F6Publishing: 11] [Article Influence: 1.6] [Reference Citation Analysis]
63 Georgiev-Hristov T, Guadalajara H, Herreros MD, Lightner AL, Dozois EJ, García-Arranz M, García-Olmo D. A Step-By-Step Surgical Protocol for the Treatment of Perianal Fistula with Adipose-Derived Mesenchymal Stem Cells. J Gastrointest Surg 2018;22:2003-12. [PMID: 30066070 DOI: 10.1007/s11605-018-3895-6] [Cited by in Crossref: 16] [Cited by in F6Publishing: 13] [Article Influence: 4.0] [Reference Citation Analysis]
64 Herreros MD, Garcia-Olmo D, Guadalajara H, Georgiev-Hristov T, Brandariz L, Garcia-Arranz M. Stem Cell Therapy: A Compassionate Use Program in Perianal Fistula. Stem Cells Int. 2019;2019:6132340. [PMID: 31191678 DOI: 10.1155/2019/6132340] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 5.0] [Reference Citation Analysis]
65 Włodarczyk M, Włodarczyk J, Sobolewska-Włodarczyk A, Trzciński R, Dziki Ł, Fichna J. Current concepts in the pathogenesis of cryptoglandular perianal fistula. J Int Med Res 2021;49:300060520986669. [PMID: 33595349 DOI: 10.1177/0300060520986669] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 4.0] [Reference Citation Analysis]
66 Segura MJ, Alós R, Solana A, Alarcón M, Ruiz MD, Lozoya R. Autologous micro-fragmented fat injection results in cases of complex perianal fistula in patients with Crohn's disease. Chirurgia 2022;35. [DOI: 10.23736/s0394-9508.21.05271-2] [Reference Citation Analysis]
67 Zhou Y, Zhao B, Zhang XL, Lu YJ, Lu ST, Cheng J, Fu Y, Lin L, Zhang NY, Li PX, Zhang J, Zhang J. Combined topical and systemic administration with human adipose-derived mesenchymal stem cells (hADSC) and hADSC-derived exosomes markedly promoted cutaneous wound healing and regeneration. Stem Cell Res Ther 2021;12:257. [PMID: 33933157 DOI: 10.1186/s13287-021-02287-9] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
68 Zwezdaryk KJ, Ferris MB, Strong AL, Morris CA, Bunnell BA, Dhurandhar NV, Gimble JM, Sullivan DE. Human cytomegalovirus infection of human adipose-derived stromal/stem cells restricts differentiation along the adipogenic lineage. Adipocyte 2016;5:53-64. [PMID: 27144097 DOI: 10.1080/21623945.2015.1119957] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 1.6] [Reference Citation Analysis]
69 Watanabe S, Arimura Y, Nagaishi K, Isshiki H, Onodera K, Nasuno M, Yamashita K, Idogawa M, Naishiro Y, Murata M, Adachi Y, Fujimiya M, Imai K, Shinomura Y. Conditioned mesenchymal stem cells produce pleiotropic gut trophic factors. J Gastroenterol. 2014;49:270-282. [PMID: 24217964 DOI: 10.1007/s00535-013-0901-3] [Cited by in Crossref: 45] [Cited by in F6Publishing: 44] [Article Influence: 5.0] [Reference Citation Analysis]
70 Pascual Miguelañez I, Alvarez Gallego M, Rubio Perez I, Funes Dueñas T, Gazo Martinez JA. Adapting fistula surgery to fistula tract and patient condition: towards a tailored treatment. Eur Surg 2016;48:4-11. [DOI: 10.1007/s10353-015-0357-1] [Reference Citation Analysis]
71 Vilchez V, Lightner AL. Surgical Management of Crohn’s’s Disease. Gastroenterology Clinics of North America 2022. [DOI: 10.1016/j.gtc.2021.12.010] [Reference Citation Analysis]
72 Chong Y, Han C, Li J, Long X. Mapping global research trends in stem cell therapy for inflammatory bowel disease: a bibliometric analysis from 1991 to 2019. J Int Med Res 2020;48:300060520965824. [PMID: 33115290 DOI: 10.1177/0300060520965824] [Reference Citation Analysis]
73 Doster DL, Jensen AR, Khaneki S, Markel TA. Mesenchymal stromal cell therapy for the treatment of intestinal ischemia: Defining the optimal cell isolate for maximum therapeutic benefit. Cytotherapy 2016;18:1457-70. [PMID: 27745788 DOI: 10.1016/j.jcyt.2016.08.001] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 1.3] [Reference Citation Analysis]
74 Park MJ, Lee SH, Moon SJ, Lee JA, Lee EJ, Kim EK, Park JS, Lee J, Min JK, Kim SJ, Park SH, Cho ML. Overexpression of soluble RAGE in mesenchymal stem cells enhances their immunoregulatory potential for cellular therapy in autoimmune arthritis. Sci Rep 2016;6:35933. [PMID: 27804999 DOI: 10.1038/srep35933] [Cited by in Crossref: 16] [Cited by in F6Publishing: 17] [Article Influence: 2.7] [Reference Citation Analysis]
75 Toyserkani NM, Jørgensen MG, Tabatabaeifar S, Jensen CH, Sheikh SP, Sørensen JA. Concise Review: A Safety Assessment of Adipose-Derived Cell Therapy in Clinical Trials: A Systematic Review of Reported Adverse Events. Stem Cells Transl Med 2017;6:1786-94. [PMID: 28722289 DOI: 10.1002/sctm.17-0031] [Cited by in Crossref: 71] [Cited by in F6Publishing: 63] [Article Influence: 14.2] [Reference Citation Analysis]
76 Kim N, Cho SG. Clinical applications of mesenchymal stem cells. Korean J Intern Med. 2013;28:387-402. [PMID: 23864795 DOI: 10.3904/kjim.2013.28.4.387] [Cited by in Crossref: 165] [Cited by in F6Publishing: 155] [Article Influence: 18.3] [Reference Citation Analysis]
77 Villiger R, Cabalzar-Wondberg D, Zeller D, Frei P, Biedermann L, Schneider C, Scharl M, Rogler G, Turina M, Rickenbacher A, Misselwitz B. Perianal fistulodesis – A pilot study of a novel minimally invasive surgical and medical approach for closure of perianal fistulae. World J Gastrointest Surg 2021; 13(2): 187-197 [PMID: 33643538 DOI: 10.4240/wjgs.v13.i2.187] [Reference Citation Analysis]
78 Kim N, Cho SG. New strategies for overcoming limitations of mesenchymal stem cell-based immune modulation. Int J Stem Cells. 2015;8:54-68. [PMID: 26019755 DOI: 10.15283/ijsc.2015.8.1.54] [Cited by in Crossref: 84] [Cited by in F6Publishing: 84] [Article Influence: 12.0] [Reference Citation Analysis]
79 Lee MJ, Heywood N, Adegbola S, Tozer P, Sahnan K, Fearnhead NS, Brown SR; ENiGMA Collaborators. Systematic review of surgical interventions for Crohn's anal fistula. BJS Open 2017;1:55-66. [PMID: 29951607 DOI: 10.1002/bjs5.13] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.8] [Reference Citation Analysis]
80 Guadalajara H, Herreros D, De-La-Quintana P, Trebol J, Garcia-Arranz M, Garcia-Olmo D. Long-term follow-up of patients undergoing adipose-derived adult stem cell administration to treat complex perianal fistulas. Int J Colorectal Dis. 2012;27:595-600. [PMID: 22065114 DOI: 10.1007/s00384-011-1350-1] [Cited by in Crossref: 121] [Cited by in F6Publishing: 101] [Article Influence: 11.0] [Reference Citation Analysis]
81 García-arranz M, Garcia-olmo D. Living medicines: Training before handling. Cytotherapy 2022. [DOI: 10.1016/j.jcyt.2021.12.007] [Reference Citation Analysis]
82 Weil BR, Manukyan MC, Herrmann JL, Abarbanell AM, Poynter JA, Wang Y, Meldrum DR. The immunomodulatory properties of mesenchymal stem cells: implications for surgical disease. J Surg Res. 2011;167:78-86. [PMID: 20869073 DOI: 10.1016/j.jss.2010.07.019] [Cited by in Crossref: 24] [Cited by in F6Publishing: 21] [Article Influence: 2.0] [Reference Citation Analysis]
83 Liras A. Future research and therapeutic applications of human stem cells: general, regulatory, and bioethical aspects. J Transl Med 2010;8:131. [PMID: 21143967 DOI: 10.1186/1479-5876-8-131] [Cited by in Crossref: 46] [Cited by in F6Publishing: 44] [Article Influence: 3.8] [Reference Citation Analysis]
84 Bermejo F, Guerra I, Algaba A, López-Sanromán A. Pharmacological Approach to the Management of Crohn's Disease Patients with Perianal Disease. Drugs 2018;78:1-18. [PMID: 29139091 DOI: 10.1007/s40265-017-0842-x] [Cited by in Crossref: 12] [Cited by in F6Publishing: 8] [Article Influence: 3.0] [Reference Citation Analysis]
85 Pogacnik JS, Salgado G. Perianal Crohn's Disease. Clin Colon Rectal Surg 2019;32:377-85. [PMID: 31507348 DOI: 10.1055/s-0039-1687834] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
86 Gilmore B, Jackson KL, Migaly J. New innovations in anal fistula surgery. Seminars in Colon and Rectal Surgery 2019;30:100707. [DOI: 10.1016/j.scrs.2019.100707] [Cited by in Crossref: 2] [Article Influence: 0.7] [Reference Citation Analysis]
87 Briquez PS, Lorentz KM, Larsson HM, Frey P, Hubbell JA. Human Kunitz-type protease inhibitor engineered for enhanced matrix retention extends longevity of fibrin biomaterials. Biomaterials 2017;135:1-9. [PMID: 28477492 DOI: 10.1016/j.biomaterials.2017.04.048] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.2] [Reference Citation Analysis]
88 Mizushima T, Takahashi H, Takeyama H, Naito A, Haraguchi N, Uemura M, Nishimura J, Hata T, Takemasa I, Yamamoto H, Doki Y, Mori M. A clinical trial of autologous adipose-derived regenerative cell transplantation for a postoperative enterocutaneous fistula. Surg Today 2016;46:835-42. [PMID: 26342817 DOI: 10.1007/s00595-015-1246-8] [Cited by in Crossref: 23] [Cited by in F6Publishing: 22] [Article Influence: 3.3] [Reference Citation Analysis]
89 Sutermaster BA, Darling EM. Considerations for high-yield, high-throughput cell enrichment: fluorescence versus magnetic sorting. Sci Rep 2019;9:227. [PMID: 30659223 DOI: 10.1038/s41598-018-36698-1] [Cited by in Crossref: 40] [Cited by in F6Publishing: 33] [Article Influence: 13.3] [Reference Citation Analysis]
90 Maddox JR, Ludlow KD, Li F, Niyibizi C. Breast and abdominal adipose multipotent mesenchymal stromal cells and stage-specific embryonic antigen 4 expression. Cells Tissues Organs. 2012;196:107-116. [PMID: 22237379 DOI: 10.1159/000331332] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 1.0] [Reference Citation Analysis]
91 Kleist C, Mohr E, Gaikwad S, Dittmar L, Kuerten S, Platten M, Mier W, Schmitt M, Opelz G, Terness P. Autoantigen-specific immunosuppression with tolerogenic peripheral blood cells prevents relapses in a mouse model of relapsing-remitting multiple sclerosis. J Transl Med 2016;14:99. [PMID: 27131971 DOI: 10.1186/s12967-016-0860-6] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 0.8] [Reference Citation Analysis]
92 Riis S, Nielsen FM, Pennisi CP, Zachar V, Fink T. Comparative Analysis of Media and Supplements on Initiation and Expansion of Adipose-Derived Stem Cells. Stem Cells Transl Med 2016;5:314-24. [PMID: 26838270 DOI: 10.5966/sctm.2015-0148] [Cited by in Crossref: 25] [Cited by in F6Publishing: 26] [Article Influence: 4.2] [Reference Citation Analysis]
93 Ommer A, Herold A, Berg E, Farke S, Fürst A, Hetzer F, Köhler A, Post S, Ruppert R, Sailer M, Schiedeck T, Strittmatter B, Lenhard B, Bader W, Gschwend J, Krammer H, Stange E. S3-Leitlinie: Kryptoglanduläre Analfisteln: AWMF-Registriernummer: 088/003. coloproctology 2011;33:295-324. [DOI: 10.1007/s00053-011-0210-3] [Cited by in Crossref: 24] [Cited by in F6Publishing: 7] [Article Influence: 2.2] [Reference Citation Analysis]
94 Ciccocioppo R, Dos Santos CC, Baumgart DC, Cangemi GC, Cardinale V, Ciacci C, De Coppi P, Haldar D, Klersy C, Nostro MC, Ott M, Piemonti L, Tomei AA, Uygun B, Vetrano S, Orlando G. Proceedings of the signature series event of the international society for cellular therapy: "Advancements in cellular therapies and regenerative medicine in digestive diseases," London, United Kingdom, May 3, 2017. Cytotherapy 2018;20:461-76. [PMID: 29398624 DOI: 10.1016/j.jcyt.2017.12.004] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
95 Lobascio P, Balducci G, Minafra M, Laforgia R, Fedele S, Conticchio M, Palasciano N. Adipose-derived stem cells (MYSTEM® EVO Technology) as a treatment for complex transsphincteric anal fistula. Tech Coloproctol 2018;22:373-7. [PMID: 29721636 DOI: 10.1007/s10151-018-1785-2] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
96 Wankhade UD, Shen M, Kolhe R, Fulzele S. Advances in Adipose-Derived Stem Cells Isolation, Characterization, and Application in Regenerative Tissue Engineering. Stem Cells Int. 2016;2016:3206807. [PMID: 26981130 DOI: 10.1155/2016/3206807] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
97 Kim DS. Intersphincteric approach for deep postanal sepsis. Ann Coloproctol 2013;29:39-40. [PMID: 23700567 DOI: 10.3393/ac.2013.29.2.39] [Reference Citation Analysis]
98 García-Arranz M, Herreros MD, González-Gómez C, de la Quintana P, Guadalajara H, Georgiev-Hristov T, Trébol J, Garcia-Olmo D. Treatment of Crohn's-Related Rectovaginal Fistula With Allogeneic Expanded-Adipose Derived Stem Cells: A Phase I-IIa Clinical Trial. Stem Cells Transl Med 2016;5:1441-6. [PMID: 27412883 DOI: 10.5966/sctm.2015-0356] [Cited by in Crossref: 68] [Cited by in F6Publishing: 55] [Article Influence: 11.3] [Reference Citation Analysis]
99 Aldahmash A, Zaher W, Al-Nbaheen M, Kassem M. Human stromal (mesenchymal) stem cells: basic biology and current clinical use for tissue regeneration. Ann Saudi Med 2012;32:68-77. [PMID: 22156642 DOI: 10.5144/0256-4947.2012.68] [Cited by in Crossref: 42] [Cited by in F6Publishing: 37] [Article Influence: 4.2] [Reference Citation Analysis]
100 Nam YS, Kim N, Im KI, Lim JY, Lee ES, Cho SG. Negative impact of bone-marrow-derived mesenchymal stem cells on dextran sulfate sodium-induced colitis. World J Gastroenterol 2015; 21(7): 2030-2039 [PMID: 25717235 DOI: 10.3748/wjg.v21.i7.2030] [Cited by in CrossRef: 13] [Cited by in F6Publishing: 16] [Article Influence: 1.9] [Reference Citation Analysis]
101 Scaldaferri F, Vetrano S. Mesenchymal Stem Cells in IBD: unMaSCing Their Therapeutic Mechanisms. Dig Dis Sci 2015;60:1873-5. [PMID: 26003558 DOI: 10.1007/s10620-015-3724-7] [Reference Citation Analysis]
102 DelaRosa O, Lombardo E. Modulation of adult mesenchymal stem cells activity by toll-like receptors: implications on therapeutic potential. Mediators Inflamm. 2010;2010:865601. [PMID: 20628526 DOI: 10.1155/2010/865601] [Cited by in Crossref: 117] [Cited by in F6Publishing: 116] [Article Influence: 9.8] [Reference Citation Analysis]
103 Huang B, Wang X, Zhou D, Chen S, Li B, Wang Y, Tai J. Treating highly complex anal fistula with a new method of combined intraoperative endoanal ultrasonography (IOEAUS) and transanal opening of intersphincteric space (TROPIS). Wideochir Inne Tech Maloinwazyjne 2021;16:697-703. [PMID: 34950264 DOI: 10.5114/wiitm.2021.104368] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
104 Tsuji W, Rubin JP, Marra KG. Adipose-derived stem cells: Implications in tissue regeneration. World J Stem Cells 2014; 6(3): 312-321 [PMID: 25126381 DOI: 10.4252/wjsc.v6.i3.312] [Cited by in Crossref: 155] [Cited by in F6Publishing: 134] [Article Influence: 19.4] [Reference Citation Analysis]
105 Lindroos B, Suuronen R, Miettinen S. The potential of adipose stem cells in regenerative medicine. Stem Cell Rev Rep. 2011;7:269-291. [PMID: 20853072 DOI: 10.1007/s12015-010-9193-7] [Cited by in Crossref: 289] [Cited by in F6Publishing: 264] [Article Influence: 26.3] [Reference Citation Analysis]
106 Soontararak S, Chow L, Johnson V, Coy J, Wheat W, Regan D, Dow S. Mesenchymal Stem Cells (MSC) Derived from Induced Pluripotent Stem Cells (iPSC) Equivalent to Adipose-Derived MSC in Promoting Intestinal Healing and Microbiome Normalization in Mouse Inflammatory Bowel Disease Model. Stem Cells Transl Med 2018;7:456-67. [PMID: 29635868 DOI: 10.1002/sctm.17-0305] [Cited by in Crossref: 45] [Cited by in F6Publishing: 47] [Article Influence: 11.3] [Reference Citation Analysis]
107 Bernardi L, Santos CHMD, Pinheiro VAZ, Oliveira RJ, Antoniolli-Silva ACMB. TRANSPLANTATION OF ADIPOSE-DERIVED MESENCHYMAL STEM CELLS IN REFRACTORY CROHN'S DISEASE: SYSTEMATIC REVIEW. Arq Bras Cir Dig 2019;32:e1465. [PMID: 31859918 DOI: 10.1590/0102-672020190001e1465] [Cited by in Crossref: 4] [Article Influence: 1.3] [Reference Citation Analysis]
108 Rahmi G, Pidial L, Silva AK, Blondiaux E, Meresse B, Gazeau F, Autret G, Balvay D, Cuenod CA, Perretta S, Tavitian B, Wilhelm C, Cellier C, Clément O. Designing 3D Mesenchymal Stem Cell Sheets Merging Magnetic and Fluorescent Features: When Cell Sheet Technology Meets Image-Guided Cell Therapy. Theranostics 2016;6:739-51. [PMID: 27022420 DOI: 10.7150/thno.14064] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 2.5] [Reference Citation Analysis]
109 Pescatori M. Surgery for anal fistulae: state of the art. Int J Colorectal Dis 2021. [PMID: 34057576 DOI: 10.1007/s00384-021-03917-7] [Reference Citation Analysis]
110 Dailey FE, Turse EP, Naseer M, Bragg JD, Tahan V. Review of stem cells as promising therapy for perianal disease in inflammatory bowel disease. World J Transplant 2018; 8(4): 97-101 [PMID: 30148075 DOI: 10.5500/wjt.v8.i4.97] [Cited by in CrossRef: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
111 Robinson AM, Miller S, Payne N, Boyd R, Sakkal S, Nurgali K. Neuroprotective Potential of Mesenchymal Stem Cell-Based Therapy in Acute Stages of TNBS-Induced Colitis in Guinea-Pigs. PLoS One 2015;10:e0139023. [PMID: 26397368 DOI: 10.1371/journal.pone.0139023] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 1.4] [Reference Citation Analysis]
112 Casteilla L, Planat-Benard V, Laharrague P, Cousin B. Adipose-derived stromal cells: Their identity and uses in clinical trials, an update. World J Stem Cells 2011; 3(4): 25-33 [PMID: 21607134 DOI: 10.4252/wjsc.v3.i4.25] [Cited by in Crossref: 154] [Cited by in F6Publishing: 142] [Article Influence: 14.0] [Reference Citation Analysis]
113 Fucini C, Giani I. Why do we have to review our experience in managing cases with idiopathic fistula-in-ano regularly? World J Gastroenterol 2011; 17(28): 3297-3299 [PMID: 21876617 DOI: 10.3748/wjg.v17.i28.3297] [Cited by in CrossRef: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
114 Rodriguez JP, Murphy MP, Hong S, Madrigal M, March KL, Minev B, Harman RJ, Chen CS, Timmons RB, Marleau AM, Riordan NH. Autologous stromal vascular fraction therapy for rheumatoid arthritis: rationale and clinical safety. Int Arch Med 2012;5:5. [PMID: 22313603 DOI: 10.1186/1755-7682-5-5] [Cited by in Crossref: 19] [Cited by in F6Publishing: 16] [Article Influence: 1.9] [Reference Citation Analysis]
115 Barco R, Encinas C, Valencia M, Carrascal M, García-arranz M, Antuña S. Use of adipose-derived stem cells in an experimental rotator cuff fracture animal model. Revista Española de Cirugía Ortopédica y Traumatología (English Edition) 2015;59:3-8. [DOI: 10.1016/j.recote.2014.11.003] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 0.6] [Reference Citation Analysis]
116 Panés J, Rimola J. Perianal fistulizing Crohn's disease: pathogenesis, diagnosis and therapy. Nat Rev Gastroenterol Hepatol 2017;14:652-64. [PMID: 28790453 DOI: 10.1038/nrgastro.2017.104] [Cited by in Crossref: 77] [Cited by in F6Publishing: 63] [Article Influence: 15.4] [Reference Citation Analysis]
117 Zuk PA. The adipose-derived stem cell: looking back and looking ahead. Mol Biol Cell. 2010;21:1783-1787. [PMID: 20375149 DOI: 10.1091/mbc.e09-07-0589] [Cited by in Crossref: 231] [Cited by in F6Publishing: 141] [Article Influence: 19.3] [Reference Citation Analysis]
118 Altemus J, Dadgar N, Li Y, Lightner AL. Adipose tissue-derived mesenchymal stem cells' acellular product extracellular vesicles as a potential therapy for Crohn's disease. J Cell Physiol 2022. [PMID: 35522572 DOI: 10.1002/jcp.30756] [Reference Citation Analysis]
119 Kim I, Bang SI, Lee SK, Park SY, Kim M, Ha H. Clinical implication of allogenic implantation of adipogenic differentiated adipose-derived stem cells. Stem Cells Transl Med 2014;3:1312-21. [PMID: 25273542 DOI: 10.5966/sctm.2014-0109] [Cited by in Crossref: 24] [Cited by in F6Publishing: 22] [Article Influence: 3.0] [Reference Citation Analysis]
120 Li P, Guo X. A review: therapeutic potential of adipose-derived stem cells in cutaneous wound healing and regeneration. Stem Cell Res Ther 2018;9:302. [PMID: 30409218 DOI: 10.1186/s13287-018-1044-5] [Cited by in Crossref: 46] [Cited by in F6Publishing: 40] [Article Influence: 11.5] [Reference Citation Analysis]
121 Jiang R, Han Z, Zhuo G, Qu X, Li X, Wang X, Shao Y, Yang S, Han ZC. Transplantation of placenta-derived mesenchymal stem cells in type 2 diabetes: a pilot study. Front Med. 2011;5:94-100. [PMID: 21681681 DOI: 10.1007/s11684-011-011-z] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
122 Choi S, Jeon BG, Chae G, Lee SJ. The clinical efficacy of stem cell therapy for complex perianal fistulas: a meta-analysis. Tech Coloproctol 2019;23:411-27. [PMID: 31049792 DOI: 10.1007/s10151-019-01994-z] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 3.0] [Reference Citation Analysis]
123 Dothel G, Raschi E, Rimondini R, De Ponti F. Mesenchymal stromal cell-based therapy: Regulatory and translational aspects in gastroenterology. World J Gastroenterol 2016; 22(41): 9057-9068 [PMID: 27895395 DOI: 10.3748/wjg.v22.i41.9057] [Cited by in CrossRef: 8] [Cited by in F6Publishing: 9] [Article Influence: 1.3] [Reference Citation Analysis]
124 Wang R, Yao Q, Chen W, Gao F, Li P, Wu J, Yu J, Cao H. Stem cell therapy for Crohn's disease: systematic review and meta-analysis of preclinical and clinical studies. Stem Cell Res Ther 2021;12:463. [PMID: 34407875 DOI: 10.1186/s13287-021-02533-0] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 8.0] [Reference Citation Analysis]
125 Ruffolo C, Citton M, Scarpa M, Angriman I, Massani M, Caratozzolo E, Bassi N. Perianal Crohn’s disease: Is there something new? World J Gastroenterol 2011; 17(15): 1939-1946 [PMID: 21528071 DOI: 10.3748/wjg.v17.i15.1939] [Cited by in CrossRef: 11] [Cited by in F6Publishing: 8] [Article Influence: 1.0] [Reference Citation Analysis]
126 Ooi YY, Rahmat Z, Jose S, Ramasamy R, Vidyadaran S. Immunophenotype and differentiation capacity of bone marrow-derived mesenchymal stem cells from CBA/Ca, ICR and Balb/c mice. World J Stem Cells 2013; 5(1): 34-42 [PMID: 23362438 DOI: 10.4252/wjsc.v5.i1.34] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 0.9] [Reference Citation Analysis]
127 Göttgens KWA, Smeets RR, Stassen LPS, Beets G, Breukink SO. Operative Verfahren bei hohen kryptoglandulären Analfisteln: Systematische Übersicht und Metaanalyse. coloproctology 2016;38:93-105. [DOI: 10.1007/s00053-015-0069-9] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
128 de la Quintana Jiménez P. [Nurse involvement in clinical trials with cell therapy]. Enferm Clin 2009;19:340-4. [PMID: 19914112 DOI: 10.1016/j.enfcli.2009.06.006] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
129 Gangadaran P, Hong CM, Ahn BC. Current Perspectives on In Vivo Noninvasive Tracking of Extracellular Vesicles with Molecular Imaging. Biomed Res Int 2017;2017:9158319. [PMID: 28246609 DOI: 10.1155/2017/9158319] [Cited by in Crossref: 57] [Cited by in F6Publishing: 62] [Article Influence: 11.4] [Reference Citation Analysis]
130 Taxonera C, Schwartz DA, García-Olmo D. Emerging treatments for complex perianal fistula in Crohn’s disease. World J Gastroenterol 2009; 15(34): 4263-4272 [PMID: 19750568 DOI: 10.3748/wjg.15.4263] [Cited by in CrossRef: 58] [Cited by in F6Publishing: 50] [Article Influence: 4.5] [Reference Citation Analysis]
131 Mishra R, Dhawan P, Srivastava AS, Singh AB. Inflammatory bowel disease: Therapeutic limitations and prospective of the stem cell therapy. World J Stem Cells 2020; 12(10): 1050-1066 [PMID: 33178391 DOI: 10.4252/wjsc.v12.i10.1050] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 2.5] [Reference Citation Analysis]
132 Zhang Y, Ni M, Zhou C, Wang Y, Wang Y, Shi Y, Jin J, Zhang R, Jiang B. Autologous adipose-derived stem cells for the treatment of complex cryptoglandular perianal fistula: a prospective case-control study. Stem Cell Res Ther 2020;11:475. [PMID: 33168077 DOI: 10.1186/s13287-020-01995-y] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
133 Lee HJ, Oh SH, Jang HW, Kwon JH, Lee KJ, Kim CH, Park SJ, Hong SP, Cheon JH, Kim TI, Kim WH. Long-Term Effects of Bone Marrow-Derived Mesenchymal Stem Cells in Dextran Sulfate Sodium-Induced Murine Chronic Colitis. Gut Liver 2016;10:412-9. [PMID: 27114436 DOI: 10.5009/gnl15229] [Cited by in Crossref: 20] [Cited by in F6Publishing: 24] [Article Influence: 4.0] [Reference Citation Analysis]
134 Patrikoski M, Mannerström B, Miettinen S. Perspectives for Clinical Translation of Adipose Stromal/Stem Cells. Stem Cells Int 2019;2019:5858247. [PMID: 31191677 DOI: 10.1155/2019/5858247] [Cited by in Crossref: 38] [Cited by in F6Publishing: 35] [Article Influence: 12.7] [Reference Citation Analysis]
135 Paradise CR, De La Vega RE, Galvan ML, Carrasco ME, Thaler R, van Wijnen AJ, Dudakovic A. Brd4 Inactivation Increases Adenoviral Delivery of BMP2 for Paracrine Stimulation of Osteogenic Differentiation as a Gene Therapeutic Concept to Enhance Bone Healing. JBMR Plus 2021;5:e10520. [PMID: 34693189 DOI: 10.1002/jbm4.10520] [Reference Citation Analysis]
136 Leto Barone AA, Khalifian S, Lee WP, Brandacher G. Immunomodulatory effects of adipose-derived stem cells: fact or fiction? Biomed Res Int 2013;2013:383685. [PMID: 24106704 DOI: 10.1155/2013/383685] [Cited by in Crossref: 61] [Cited by in F6Publishing: 62] [Article Influence: 6.8] [Reference Citation Analysis]
137 Machielsen AJHM, Iqbal N, Kimman ML, Sahnan K, Adegbola SO, Kane G, Woodcock R, Kleijnen J, Grossi U, Breukink SO, Tozer PJ. Heterogeneity in outcome selection, definition and measurement in studies assessing the treatment of cryptoglandular anal fistula: findings from a systematic review. Tech Coloproctol 2021;25:761-830. [PMID: 33963945 DOI: 10.1007/s10151-021-02452-5] [Reference Citation Analysis]
138 Schreiner P, Neurath MF, Ng SC, El-Omar EM, Sharara AI, Kobayashi T, Hisamatsu T, Hibi T, Rogler G. Mechanism-Based Treatment Strategies for IBD: Cytokines, Cell Adhesion Molecules, JAK Inhibitors, Gut Flora, and More. Inflamm Intest Dis 2019;4:79-96. [PMID: 31559260 DOI: 10.1159/000500721] [Cited by in Crossref: 23] [Cited by in F6Publishing: 24] [Article Influence: 7.7] [Reference Citation Analysis]
139 Oses C, Olivares B, Ezquer M, Acosta C, Bosch P, Donoso M, Léniz P, Ezquer F, Kirchmair R. Preconditioning of adipose tissue-derived mesenchymal stem cells with deferoxamine increases the production of pro-angiogenic, neuroprotective and anti-inflammatory factors: Potential application in the treatment of diabetic neuropathy. PLoS ONE 2017;12:e0178011. [DOI: 10.1371/journal.pone.0178011] [Cited by in Crossref: 52] [Cited by in F6Publishing: 54] [Article Influence: 10.4] [Reference Citation Analysis]
140 Xie H, Liao N, Lan F, Cai Z, Liu X, Liu J. 3D-cultured adipose tissue-derived stem cells inhibit liver cancer cell migration and invasion through suppressing epithelial-mesenchymal transition. Int J Mol Med 2018;41:1385-96. [PMID: 29286072 DOI: 10.3892/ijmm.2017.3336] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
141 Sheikh P, Baakza A. Management of Fistula-in-Ano-The Current Evidence. Indian J Surg 2014;76:482-6. [PMID: 25614724 DOI: 10.1007/s12262-014-1150-2] [Cited by in Crossref: 14] [Article Influence: 2.0] [Reference Citation Analysis]
142 Ciccocioppo R, Klersy C, Leffler DA, Rogers R, Bennett D, Corazza GR. Systematic review with meta-analysis: Safety and efficacy of local injections of mesenchymal stem cells in perianal fistulas. JGH Open. 2019;3:249-260. [PMID: 31276044 DOI: 10.1002/jgh3.12141] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 4.3] [Reference Citation Analysis]
143 Chen Y, Li C, Ji W, Wang L, Chen X, Zhao S, Xu Z, Ge R, Guo X. Differentiation of human adipose derived stem cells into Leydig-like cells with molecular compounds. J Cell Mol Med 2019;23:5956-69. [PMID: 31293077 DOI: 10.1111/jcmm.14427] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
144 Hui CK, Safwani WKZW, Chin SS, Malek AASA, Hassan N, Fazil MS, Rooshdi RAWRM, Hamid AA, Sathappan S. Human serum promotes the proliferation but not the stemness genes expression of human adipose-derived stem cells. Biotechnol Bioproc E 2012;17:1306-13. [DOI: 10.1007/s12257-012-0354-1] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
145 Casiraghi F, Remuzzi G, Abbate M, Perico N. Multipotent mesenchymal stromal cell therapy and risk of malignancies. Stem Cell Rev. 2013;9:65-79. [PMID: 22237468 DOI: 10.1007/s12015-011-9345-4] [Cited by in Crossref: 86] [Cited by in F6Publishing: 83] [Article Influence: 9.6] [Reference Citation Analysis]
146 Baker KF, Isaacs JD. Prospects for therapeutic tolerance in humans. Curr Opin Rheumatol 2014;26:219-27. [PMID: 24378931 DOI: 10.1097/BOR.0000000000000029] [Cited by in Crossref: 11] [Cited by in F6Publishing: 6] [Article Influence: 1.4] [Reference Citation Analysis]
147 Jiang R, Han Z, Zhuo G, Qu X, Li X, Wang X, Shao Y, Yang S, Han ZC. Transplantation of placenta-derived mesenchymal stem cells in type 2 diabetes: a pilot study. Front Med. 2011;5:94-100. [PMID: 21681681 DOI: 10.1007/s11684-011-0116-z] [Cited by in Crossref: 133] [Cited by in F6Publishing: 119] [Article Influence: 12.1] [Reference Citation Analysis]
148 Barnhoorn MC, Wasser MNJM, Roelofs H, Maljaars PWJ, Molendijk I, Bonsing BA, Oosten LEM, Dijkstra G, van der Woude CJ, Roelen DL, Zwaginga JJ, Verspaget HW, Fibbe WE, Hommes DW, Peeters KCMJ, van der Meulen-de Jong AE. Long-term Evaluation of Allogeneic Bone Marrow-derived Mesenchymal Stromal Cell Therapy for Crohn's Disease Perianal Fistulas. J Crohns Colitis. 2020;14:64-70. [PMID: 31197361 DOI: 10.1093/ecco-jcc/jjz116] [Cited by in Crossref: 15] [Cited by in F6Publishing: 21] [Article Influence: 7.5] [Reference Citation Analysis]
149 Kim I, Lee SK, Yoon JI, Kim DE, Kim M, Ha H. Fibrin glue improves the therapeutic effect of MSCs by sustaining survival and paracrine function. Tissue Eng Part A 2013;19:2373-81. [PMID: 23701237 DOI: 10.1089/ten.TEA.2012.0665] [Cited by in Crossref: 45] [Cited by in F6Publishing: 41] [Article Influence: 5.0] [Reference Citation Analysis]
150 Hanson SE, Gutowski KA, Hematti P. Clinical applications of mesenchymal stem cells in soft tissue augmentation. Aesthet Surg J. 2010;30:838-842. [PMID: 21131458 DOI: 10.1177/1090820X10386364] [Cited by in Crossref: 37] [Cited by in F6Publishing: 13] [Article Influence: 3.4] [Reference Citation Analysis]
151 Lopez N, Ramamoorthy S, Sandborn WJ. Recent advances in the management of perianal fistulizing Crohn's disease: lessons for the clinic. Expert Rev Gastroenterol Hepatol. 2019;13:563-577. [PMID: 31023087 DOI: 10.1080/17474124.2019.1608818] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 2.3] [Reference Citation Analysis]
152 Fan XL, Zhang Y, Li X, Fu QL. Mechanisms underlying the protective effects of mesenchymal stem cell-based therapy. Cell Mol Life Sci. 2020;77:2771-2794. [PMID: 31965214 DOI: 10.1007/s00018-020-03454-6] [Cited by in Crossref: 83] [Cited by in F6Publishing: 88] [Article Influence: 41.5] [Reference Citation Analysis]
153 Cai L, Dewi RE, Heilshorn SC. Injectable Hydrogels with In Situ Double Network Formation Enhance Retention of Transplanted Stem Cells. Adv Funct Mater 2015;25:1344-51. [PMID: 26273242 DOI: 10.1002/adfm.201403631] [Cited by in Crossref: 170] [Cited by in F6Publishing: 157] [Article Influence: 24.3] [Reference Citation Analysis]
154 Martínez-Montiel Mdel P, Gómez-Gómez GJ, Flores AI. Therapy with stem cells in inflammatory bowel disease. World J Gastroenterol 2014;20:1211-27. [PMID: 24574796 DOI: 10.3748/wjg.v20.i5.1211] [Cited by in CrossRef: 40] [Cited by in F6Publishing: 41] [Article Influence: 5.0] [Reference Citation Analysis]
155 Gallo G, Tiesi V, Fulginiti S, De Paola G, Vescio G, Sammarco G. Mesenchymal Stromal Cell Therapy in the Management of Perianal Fistulas in Crohn's Disease: An Up-To-Date Review. Medicina (Kaunas) 2020;56:E563. [PMID: 33121049 DOI: 10.3390/medicina56110563] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
156 Ra JC, Jeong EC, Kang SK, Lee SJ, Choi KH. A Prospective, Nonrandomized, no Placebo-Controlled, Phase I/II Clinical Trial Assessing the Safety and Efficacy of Intramuscular Injection of Autologous Adipose Tissue-Derived Mesenchymal Stem Cells in Patients With Severe Buerger's Disease. Cell Med 2017;9:87-102. [PMID: 28713639 DOI: 10.3727/215517916X693069] [Cited by in Crossref: 14] [Cited by in F6Publishing: 8] [Article Influence: 2.3] [Reference Citation Analysis]
157 Zhang J, Liu Y, Yin W, Hu X. Adipose-derived stromal cells in regulation of hematopoiesis. Cell Mol Biol Lett 2020;25:16. [PMID: 32161623 DOI: 10.1186/s11658-020-00209-w] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
158 Simonacci F, Bertozzi N, Raposio E. Off-label use of adipose-derived stem cells. Ann Med Surg (Lond) 2017;24:44-51. [PMID: 29123656 DOI: 10.1016/j.amsu.2017.10.023] [Cited by in Crossref: 18] [Cited by in F6Publishing: 15] [Article Influence: 3.6] [Reference Citation Analysis]
159 Marel SVD, Majowicz A, Deventer SV, Petry H, Hommes DW, Ferreira V. Gene and cell therapy based treatment strategies for inflammatory bowel diseases. World J Gastrointest Pathophysiol 2011; 2(6): 114-122 [PMID: 22180846 DOI: 10.4291/wjgp.v2.i6.114] [Cited by in CrossRef: 16] [Cited by in F6Publishing: 17] [Article Influence: 1.5] [Reference Citation Analysis]
160 Mosanya CH, Isaacs JD. Tolerising cellular therapies: what is their promise for autoimmune disease? Ann Rheum Dis 2019;78:297-310. [PMID: 30389690 DOI: 10.1136/annrheumdis-2018-214024] [Cited by in Crossref: 20] [Cited by in F6Publishing: 16] [Article Influence: 5.0] [Reference Citation Analysis]
161 El-Nakeep S, Shawky A, Abbas SF, Abdel Latif O. Stem cell transplantation for induction of remission in medically refractory Crohn's disease. Cochrane Database Syst Rev 2022;5:CD013070. [PMID: 35556242 DOI: 10.1002/14651858.CD013070.pub2] [Reference Citation Analysis]
162 Fierro FA, Kalomoiris S, Sondergaard CS, Nolta JA. Effects on proliferation and differentiation of multipotent bone marrow stromal cells engineered to express growth factors for combined cell and gene therapy. Stem Cells 2011;29:1727-37. [PMID: 21898687 DOI: 10.1002/stem.720] [Cited by in Crossref: 92] [Cited by in F6Publishing: 88] [Article Influence: 9.2] [Reference Citation Analysis]
163 Zhou C, Li M, Zhang Y, Ni M, Wang Y, Xu D, Shi Y, Zhang B, Chen Y, Huang Y, Zhang S, Shi H, Jiang B. Autologous adipose-derived stem cells for the treatment of Crohn's fistula-in-ano: an open-label, controlled trial. Stem Cell Res Ther 2020;11:124. [PMID: 32183875 DOI: 10.1186/s13287-020-01636-4] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 5.5] [Reference Citation Analysis]
164 Adegbola SO, Pisani A, Sahnan K, Tozer P, Ellul P, Warusavitarne J. Medical and surgical management of perianal Crohn's disease. Ann Gastroenterol 2018;31:129-39. [PMID: 29507460 DOI: 10.20524/aog.2018.0236] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
165 Cheng F, Huang Z, Li Z. Efficacy and Safety of Mesenchymal Stem Cells in Treatment of Complex Perianal Fistulas: A Meta-Analysis. Stem Cells Int 2020;2020:8816737. [PMID: 33299423 DOI: 10.1155/2020/8816737] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
166 Włodarczyk M, Czerwińska K, Włodarczyk J, Fichna J, Dziki A, Dziki Ł. Current Overview on the Use of Mesenchymal Stem Cells for Perianal Fistula Treatment in Patients with Crohn's Disease. Life (Basel) 2021;11:1133. [PMID: 34833009 DOI: 10.3390/life11111133] [Reference Citation Analysis]
167 López-Holgado N, López-Villar O, Sánchez-Guijo FM, del Cañizo MC. [Cell-Production Units for stem cell clinical research: basic aspects for their development and optimization]. Med Clin (Barc) 2012;138:31-6. [PMID: 21376351 DOI: 10.1016/j.medcli.2010.10.014] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
168 Martin I, Baldomero H, Bocelli-Tyndall C, Slaper-Cortenbach I, Passweg J, Tyndall A. The survey on cellular and engineered tissue therapies in Europe in 2009. Tissue Eng Part A 2011;17:2221-30. [PMID: 21542713 DOI: 10.1089/ten.TEA.2011.0131] [Cited by in Crossref: 27] [Cited by in F6Publishing: 27] [Article Influence: 2.7] [Reference Citation Analysis]
169 Fierro FA, Nolta JA, Adamopoulos IE. Concise Review: Stem Cells in Osteoimmunology. Stem Cells 2017;35:1461-7. [PMID: 28390147 DOI: 10.1002/stem.2625] [Cited by in Crossref: 25] [Cited by in F6Publishing: 26] [Article Influence: 5.0] [Reference Citation Analysis]
170 Rastegar F, Shenaq D, Huang J, Zhang W, Zhang BQ, He BC, Chen L, Zuo GW, Luo Q, Shi Q, Wagner ER, Huang E, Gao Y, Gao JL, Kim SH, Zhou JZ, Bi Y, Su Y, Zhu G, Luo J, Luo X, Qin J, Reid RR, Luu HH, Haydon RC, Deng ZL, He TC. Mesenchymal stem cells: Molecular characteristics and clinical applications. World J Stem Cells 2010; 2(4): 67-80 [PMID: 21607123 DOI: 10.4252/wjsc.v2.i4.67] [Cited by in Crossref: 130] [Cited by in F6Publishing: 128] [Article Influence: 10.8] [Reference Citation Analysis]
171 Wen YL, Niu JK, Miao YL. Non-drug treatment of inflammatory bowel disease. Shijie Huaren Xiaohua Zazhi 2015; 23(23): 3720-3728 [DOI: 10.11569/wcjd.v23.i23.3720] [Reference Citation Analysis]
172 De Francesco F, Romano M, Zarantonello L, Ruffolo C, Neri D, Bassi N, Giordano A, Zanus G, Ferraro GA, Cillo U. The role of adipose stem cells in inflammatory bowel disease: From biology to novel therapeutic strategies. Cancer Biol Ther. 2016;17:889-898. [PMID: 27414952 DOI: 10.1080/15384047.2016.1210741] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 1.8] [Reference Citation Analysis]
173 Zheng GP, Ge MH, Shu Q, Rojas M, Xu J. Mesenchymal stem cells in the treatment of pediatric diseases. World J Pediatr 2013;9:197-211. [PMID: 23929252 DOI: 10.1007/s12519-013-0425-1] [Cited by in Crossref: 14] [Cited by in F6Publishing: 9] [Article Influence: 1.6] [Reference Citation Analysis]
174 Cooper GM, Durham EL, Cray JJ Jr, Bykowski MR, DeCesare GE, Smalley MA, Mooney MP, Campbell PG, Losee JE. Direct comparison of progenitor cells derived from adipose, muscle, and bone marrow from wild-type or craniosynostotic rabbits. Plast Reconstr Surg 2011;127:88-97. [PMID: 20871482 DOI: 10.1097/PRS.0b013e3181fad311] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 0.9] [Reference Citation Analysis]
175 Amato A, Bottini C, De Nardi P, Giamundo P, Lauretta A, Realis Luc A, Tegon G, Nicholls RJ; Italian society of colorectal surgery. Evaluation and management of perianal abscess and anal fistula: a consensus statement developed by the Italian Society of Colorectal Surgery (SICCR). Tech Coloproctol 2015;19:595-606. [PMID: 26377581 DOI: 10.1007/s10151-015-1365-7] [Cited by in Crossref: 35] [Cited by in F6Publishing: 24] [Article Influence: 5.0] [Reference Citation Analysis]
176 Song KH. New techniques for treating an anal fistula. J Korean Soc Coloproctol 2012;28:7-12. [PMID: 22413076 DOI: 10.3393/jksc.2012.28.1.7] [Cited by in Crossref: 14] [Cited by in F6Publishing: 10] [Article Influence: 1.4] [Reference Citation Analysis]
177 Barnhoorn MC, Hakuno SK, Bruckner RS, Rogler G, Hawinkels LJAC, Scharl M. Stromal Cells in the Pathogenesis of Inflammatory Bowel Disease. J Crohns Colitis 2020;14:995-1009. [PMID: 32160284 DOI: 10.1093/ecco-jcc/jjaa009] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 7.0] [Reference Citation Analysis]
178 Sanz-Baro R, García-Arranz M, Guadalajara H, de la Quintana P, Herreros MD, García-Olmo D. First-in-Human Case Study: Pregnancy in Women With Crohn's Perianal Fistula Treated With Adipose-Derived Stem Cells: A Safety Study. Stem Cells Transl Med 2015;4:598-602. [PMID: 25925838 DOI: 10.5966/sctm.2014-0255] [Cited by in Crossref: 25] [Cited by in F6Publishing: 26] [Article Influence: 3.6] [Reference Citation Analysis]
179 Pascual I, Fernández de Miguel G, García Arranz M, García-Olmo D. Biosutures improve healing of experimental weak colonic anastomoses. Int J Colorectal Dis 2010;25:1447-51. [PMID: 20544210 DOI: 10.1007/s00384-010-0952-3] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 0.9] [Reference Citation Analysis]
180 Nagaishi K, Arimura Y, Fujimiya M. Stem cell therapy for inflammatory bowel disease. J Gastroenterol. 2015;50:280-286. [PMID: 25618180 DOI: 10.1007/s00535-015-1040-9] [Cited by in Crossref: 40] [Cited by in F6Publishing: 43] [Article Influence: 5.7] [Reference Citation Analysis]
181 Amato A, Bottini C, De Nardi P, Giamundo P, Lauretta A, Realis Luc A, Piloni V. Evaluation and management of perianal abscess and anal fistula: SICCR position statement. Tech Coloproctol. 2020;24:127-143. [PMID: 31974827 DOI: 10.1007/s10151-019-02144-1] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 5.5] [Reference Citation Analysis]
182 Roux S, Leotot J, Chevallier N, Bierling P, Rouard H. [Mesenchymal stromal cells: Biological properties and clinical prospects]. Transfus Clin Biol 2011;18:1-12. [PMID: 21367635 DOI: 10.1016/j.tracli.2011.01.001] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
183 Kubrova E, Qu W, Galvan ML, Paradise CR, Yang J, Dietz AB, Dudakovic A, Smith J, van Wijnen AJ. Hypothermia and nutrient deprivation alter viability of human adipose-derived mesenchymal stem cells. Gene 2020;722:144058. [PMID: 31494240 DOI: 10.1016/j.gene.2019.144058] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
184 Al-toma A, Nijeboer P, Bouma G, Visser O, Mulder CJ. Hematopoietic stem cell transplantation for non-malignant gastrointestinal diseases. World J Gastroenterol 2014; 20(46): 17368-17375 [PMID: 25516648 DOI: 10.3748/wjg.v20.i46.17368] [Cited by in CrossRef: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.9] [Reference Citation Analysis]
185 Wankhade UD, Shen M, Kolhe R, Fulzele S. Advances in Adipose-Derived Stem Cells Isolation, Characterization, and Application in Regenerative Tissue Engineering. Stem Cells Int 2016;2016:3206807. [PMID: 26981130 DOI: 10.1155/2016/3206807] [Reference Citation Analysis]
186 Schouten WR, Arkenbosch JHC, van der Woude CJ, de Vries AC, Stevens HP, Fuhler GM, Dwarkasing RS, van Ruler O, de Graaf EJR. Efficacy and safety of autologous adipose-derived stromal vascular fraction enriched with platelet-rich plasma in flap repair of transsphincteric cryptoglandular fistulas. Tech Coloproctol 2021;25:1301-9. [PMID: 34606026 DOI: 10.1007/s10151-021-02524-6] [Reference Citation Analysis]
187 Brown AC, Barker TH. Fibrin-based biomaterials: modulation of macroscopic properties through rational design at the molecular level. Acta Biomater 2014;10:1502-14. [PMID: 24056097 DOI: 10.1016/j.actbio.2013.09.008] [Cited by in Crossref: 125] [Cited by in F6Publishing: 116] [Article Influence: 13.9] [Reference Citation Analysis]
188 Schiano di Visconte M, Bellio G. Comparison of porcine collagen paste injection and rectal advancement flap for the treatment of complex cryptoglandular anal fistulas: a 2-year follow-up study. Int J Colorectal Dis 2018;33:1723-31. [PMID: 30187158 DOI: 10.1007/s00384-018-3154-z] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
189 Martín Arranz E, Martín Arranz MD, Robredo T, Mancheño-Corvo P, Menta R, Alves FJ, Suárez de Parga JM, Mora Sanz P, de la Rosa O, Büscher D, Lombardo E, de Miguel F. Endoscopic submucosal injection of adipose-derived mesenchymal stem cells ameliorates TNBS-induced colitis in rats and prevents stenosis. Stem Cell Res Ther 2018;9:95. [PMID: 29631607 DOI: 10.1186/s13287-018-0837-x] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
190 Cheng F, Huang Z, Li Z. Mesenchymal stem-cell therapy for perianal fistulas in Crohn's disease: a systematic review and meta-analysis. Tech Coloproctol. 2019;23:613-623. [PMID: 31286287 DOI: 10.1007/s10151-019-02024-8] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 3.3] [Reference Citation Analysis]
191 Silva KR, Liechocki S, Carneiro JR, Claudio-da-Silva C, Maya-Monteiro CM, Borojevic R, Baptista LS. Stromal-vascular fraction content and adipose stem cell behavior are altered in morbid obese and post bariatric surgery ex-obese women. Stem Cell Res Ther. 2015;6:72. [PMID: 25884374 DOI: 10.1186/s13287-015-0029-x] [Cited by in Crossref: 31] [Cited by in F6Publishing: 32] [Article Influence: 4.4] [Reference Citation Analysis]
192 Rossignol DA. Hyperbaric oxygen treatment for inflammatory bowel disease: a systematic review and analysis. Med Gas Res. 2012;2:6. [PMID: 22417628 DOI: 10.1186/2045-9912-2-6] [Cited by in Crossref: 21] [Cited by in F6Publishing: 20] [Article Influence: 2.1] [Reference Citation Analysis]
193 Göttgens KW, Smeets RR, Stassen LP, Beets G, Breukink SO. Systematic review and meta-analysis of surgical interventions for high cryptoglandular perianal fistula. Int J Colorectal Dis 2015;30:583-93. [PMID: 25487858 DOI: 10.1007/s00384-014-2091-8] [Cited by in Crossref: 45] [Cited by in F6Publishing: 36] [Article Influence: 5.6] [Reference Citation Analysis]
194 Robinson AM, Rahman AA, Miller S, Stavely R, Sakkal S, Nurgali K. The neuroprotective effects of human bone marrow mesenchymal stem cells are dose-dependent in TNBS colitis. Stem Cell Res Ther 2017;8:87. [PMID: 28420434 DOI: 10.1186/s13287-017-0540-3] [Cited by in Crossref: 12] [Cited by in F6Publishing: 14] [Article Influence: 2.4] [Reference Citation Analysis]
195 Cwaliński J, Hermann J, Paszkowski J, Banasiewicz T. Minimally Invasive Treatment of Recurrent Anal Fistulas with Autologous Platelet-Rich Plasma Combined With Internal Orifice Closure. Surg Innov. [DOI: 10.1177/15533506221086778] [Reference Citation Analysis]
196 García-Olmo D, García-Arranz M. [Cells for curing. From the heart to everything]. An Pediatr (Barc) 2011;74:215-7. [PMID: 21459345 DOI: 10.1016/j.anpedi.2011.02.021] [Reference Citation Analysis]
197 Gentile P, Orlandi A, Scioli MG, Di Pasquali C, Bocchini I, Curcio CB, Floris M, Fiaschetti V, Floris R, Cervell V. A comparative translational study: the combined use of enhanced stromal vascular fraction and platelet-rich plasma improves fat grafting maintenance in breast reconstruction. Stem Cells Transl Med 2012;1:341-51. [PMID: 23197813 DOI: 10.5966/sctm.2011-0065] [Cited by in Crossref: 126] [Cited by in F6Publishing: 118] [Article Influence: 12.6] [Reference Citation Analysis]
198 Wankhade UD, Shen M, Kolhe R, Fulzele S. Advances in Adipose-Derived Stem Cells Isolation, Characterization, and Application in Regenerative Tissue Engineering. Stem Cells Int 2016;2016:3206807. [PMID: 26981130 DOI: 10.1155/2016/3206807] [Cited by in Crossref: 73] [Cited by in F6Publishing: 71] [Article Influence: 12.2] [Reference Citation Analysis]
199 Limura E, Giordano P. Modern management of anal fistula. World J Gastroenterol 2015; 21(1): 12-20 [PMID: 25574077 DOI: 10.3748/wjg.v21.i1.12] [Cited by in CrossRef: 87] [Cited by in F6Publishing: 54] [Article Influence: 12.4] [Reference Citation Analysis]
200 Qiu Y, Li MY, Feng T, Feng R, Mao R, Chen BL, He Y, Zeng ZR, Zhang SH, Chen MH. Systematic review with meta-analysis: the efficacy and safety of stem cell therapy for Crohn's disease. Stem Cell Res Ther 2017;8:136. [PMID: 28583202 DOI: 10.1186/s13287-017-0570-x] [Cited by in Crossref: 19] [Cited by in F6Publishing: 16] [Article Influence: 3.8] [Reference Citation Analysis]
201 Xie M, Qin H, Luo Q, He X, He X, Lan P, Lian L. Comparison of Adipose-Derived and Bone Marrow Mesenchymal Stromal Cells in a Murine Model of Crohn's Disease. Dig Dis Sci 2017;62:115-23. [PMID: 27107864 DOI: 10.1007/s10620-016-4166-6] [Cited by in Crossref: 17] [Cited by in F6Publishing: 18] [Article Influence: 2.8] [Reference Citation Analysis]
202 He Y, Lu F. Development of Synthetic and Natural Materials for Tissue Engineering Applications Using Adipose Stem Cells. Stem Cells Int. 2016;2016:5786257. [PMID: 26977158 DOI: 10.1155/2016/5786257] [Cited by in Crossref: 23] [Cited by in F6Publishing: 17] [Article Influence: 3.8] [Reference Citation Analysis]
203 Coalson E, Bishop E, Liu W, Feng Y, Spezia M, Liu B, Shen Y, Wu D, Du S, Li AJ, Ye Z, Zhao L, Cao D, Li A, Hagag O, Deng A, Liu W, Li M, Haydon RC, Shi L, Athiviraham A, Lee MJ, Wolf JM, Ameer GA, He TC, Reid RR. Stem cell therapy for chronic skin wounds in the era of personalized medicine: From bench to bedside. Genes Dis. 2019;6:342-358. [PMID: 31832514 DOI: 10.1016/j.gendis.2019.09.008] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 4.3] [Reference Citation Analysis]
204 Krampera M, Le Blanc K. Mesenchymal stromal cells: Putative microenvironmental modulators become cell therapy. Cell Stem Cell 2021;28:1708-25. [PMID: 34624232 DOI: 10.1016/j.stem.2021.09.006] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
205 Mazzanti B, Lorenzi B, Borghini A, Boieri M, Ballerini L, Saccardi R, Weber E, Pessina F. Local injection of bone marrow progenitor cells for the treatment of anal sphincter injury: in-vitro expanded versus minimally-manipulated cells. Stem Cell Res Ther. 2016;7:85. [PMID: 27328811 DOI: 10.1186/s13287-016-0344-x] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 2.0] [Reference Citation Analysis]
206 Naldini G, Sturiale A, Fabiani B, Giani I, Menconi C. Micro-fragmented adipose tissue injection for the treatment of complex anal fistula: a pilot study accessing safety and feasibility. Tech Coloproctol 2018;22:107-13. [PMID: 29453515 DOI: 10.1007/s10151-018-1755-8] [Cited by in Crossref: 16] [Cited by in F6Publishing: 12] [Article Influence: 4.0] [Reference Citation Analysis]
207 Saba RB, Tizmaghz A, Ajeka S, Karami M. Treating anal fistula with the anal fistula plug: case series report of 12 patients. Electron Physician 2016;8:2304-7. [PMID: 27280009 DOI: 10.19082/2303] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
208 Jongen J, Kahlke V, Laubert T. Biomaterialien, Laser, VAAFT, OTSC – aktueller Stand? coloproctology 2019;41:416-21. [DOI: 10.1007/s00053-019-00389-w] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
209 Mancheño-Corvo P, Franquesa M, de la Rosa O, Ramírez C, García-Benzaquén L, Fernández V, Menta R, Beraza A, Dalemans W, Hoogduijn MJ, Lombardo E. Adipose mesenchymal stromal cell function is not affected by methotrexate and azathioprine. Biores Open Access 2013;2:431-9. [PMID: 24380053 DOI: 10.1089/biores.2013.0040] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.8] [Reference Citation Analysis]
210 Wang H, Fei B, Jin H. Complex anal fistula: A case report. Int J Surg Case Rep 2020;77:782-6. [PMID: 33395895 DOI: 10.1016/j.ijscr.2020.11.056] [Reference Citation Analysis]
211 Spotnitz WD. Fibrin sealant: past, present, and future: a brief review. World J Surg. 2010;34:632-634. [PMID: 19820991 DOI: 10.1007/s00268-009-0252-7] [Cited by in Crossref: 186] [Cited by in F6Publishing: 158] [Article Influence: 15.5] [Reference Citation Analysis]
212 Hanson SE, Bentz ML, Hematti P. Mesenchymal stem cell therapy for nonhealing cutaneous wounds. Plast Reconstr Surg. 2010;125:510-516. [PMID: 20124836 DOI: 10.1097/prs.0b013e3181c722bb] [Cited by in Crossref: 101] [Cited by in F6Publishing: 40] [Article Influence: 8.4] [Reference Citation Analysis]
213 Hareendran S, Sathishkumar S, Abbas S, Mackay AM, Rajan P. A novel composition for the culture of human adipose stem cells which includes complement C3. Cytotechnology. 2010;62:389-402. [PMID: 20835846 DOI: 10.1007/s10616-010-9301-1] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
214 Soliman F, Sturgeon G, Hargest R. Revisiting an ancient treatment for transphincteric fistula-in-ano 'There is nothing new under the sun' Ecclesiastes 1v9. J R Soc Med 2015;108:482-9. [PMID: 26152674 DOI: 10.1177/0141076815588322] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 0.9] [Reference Citation Analysis]
215 Seyfried S, Herold A. Management of Perianal Fistulas in Crohn's Disease. Visc Med. 2019;35:338-343. [PMID: 31934580 DOI: 10.1159/000504103] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
216 Philippe B, Luc S, Valérie PB, Jérôme R, Alessandra BR, Louis C. Culture and Use of Mesenchymal Stromal Cells in Phase I and II Clinical Trials. Stem Cells Int 2010;2010:503593. [PMID: 21052537 DOI: 10.4061/2010/503593] [Cited by in Crossref: 37] [Cited by in F6Publishing: 35] [Article Influence: 3.1] [Reference Citation Analysis]
217 Cervelli V, Scioli MG, Gentile P, Doldo E, Bonanno E, Spagnoli LG, Orlandi A. Platelet-rich plasma greatly potentiates insulin-induced adipogenic differentiation of human adipose-derived stem cells through a serine/threonine kinase Akt-dependent mechanism and promotes clinical fat graft maintenance. Stem Cells Transl Med. 2012;1:206-220. [PMID: 23197780 DOI: 10.5966/sctm.2011-0052] [Cited by in Crossref: 108] [Cited by in F6Publishing: 107] [Article Influence: 10.8] [Reference Citation Analysis]
218 Parisi-Amon A, Mulyasasmita W, Chung C, Heilshorn SC. Protein-engineered injectable hydrogel to improve retention of transplanted adipose-derived stem cells. Adv Healthc Mater 2013;2:428-32. [PMID: 23184882 DOI: 10.1002/adhm.201200293] [Cited by in Crossref: 96] [Cited by in F6Publishing: 89] [Article Influence: 9.6] [Reference Citation Analysis]
219 Voswinkel J, Chapel A. [Mesenchymal stem cells and rheumatism. State of the art]. Z Rheumatol 2012;71:619-23. [PMID: 22825552 DOI: 10.1007/s00393-011-0950-z] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 0.7] [Reference Citation Analysis]
220 Lu GM, Rong YX, Liang ZJ, Hunag DL, Wu FX, Ma YF, Luo ZZ, Liu XH, Mo S, Li HM. FGF2-induced PI3K/Akt signaling evokes greater proliferation and adipogenic differentiation of human adipose stem cells from breast than from abdomen or thigh. Aging (Albany NY) 2020;12:14830-48. [PMID: 32706337 DOI: 10.18632/aging.103547] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
221 Cho YJ, Kwon H, Kwon YJ, Kim KM, Oh SH, Kim DY. Efficacy and safety of autologous adipose tissue-derived stem cell therapy for children with refractory Crohn's complex fistula: a Phase IV clinical study. Ann Surg Treat Res 2021;101:58-64. [PMID: 34235117 DOI: 10.4174/astr.2021.101.1.58] [Reference Citation Analysis]
222 Taylor JP, Gearhart S. The use of viable cryopreserved placental tissue in the management of a chronic rectovaginal fistula. Ann R Coll Surg Engl 2017;99:e236-40. [PMID: 29046080 DOI: 10.1308/rcsann.2017.0157] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.6] [Reference Citation Analysis]
223 Dave M, Mehta K, Luther J, Baruah A, Dietz AB, Faubion WA. Mesenchymal Stem Cell Therapy for Inflammatory Bowel Disease: A Systematic Review and Meta-analysis. Inflamm Bowel Dis. 2015;21:2696-2707. [PMID: 26230863 DOI: 10.1097/mib.0000000000000543] [Cited by in Crossref: 57] [Cited by in F6Publishing: 33] [Article Influence: 9.5] [Reference Citation Analysis]
224 Kochhar G, Saha S, Andley M, Kumar A, Saurabh G, Pusuluri R, Bhise V, Kumar A. Video-assisted anal fistula treatment. JSLS 2014;18:e2014. [PMID: 25419106 DOI: 10.4293/JSLS.2014.00127] [Cited by in Crossref: 18] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
225 Trébol J, Georgiev-Hristov T, Vega-Clemente L, García-Gómez I, Carabias-Orgaz A, García-Arranz M, García-Olmo D. Rat model of anal sphincter injury and two approaches for stem cell administration. World J Stem Cells 2018; 10(1): 1-14 [PMID: 29391927 DOI: 10.4252/wjsc.v10.i1.1] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 1.5] [Reference Citation Analysis]
226 Karakaş N, Üçüncüoğlu S, Uludağ D, Karaoğlan BS, Shah K, Öztürk G. Mesenchymal Stem Cell-Based COVID-19 Therapy: Bioengineering Perspectives. Cells 2022;11:465. [DOI: 10.3390/cells11030465] [Reference Citation Analysis]
227 Yan XZ, van den Beucken JJ, Both SK, Yang PS, Jansen JA, Yang F. Biomaterial strategies for stem cell maintenance during in vitro expansion. Tissue Eng Part B Rev 2014;20:340-54. [PMID: 24168361 DOI: 10.1089/ten.TEB.2013.0349] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 2.0] [Reference Citation Analysis]
228 Vaughn BP, Moss AC. Novel treatment options for ulcerative colitis. Clin Investig (Lond) 2013;3:1057-69. [PMID: 24533177 DOI: 10.4155/cli.13.97] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
229 Wang Q, He Y, Shen J. The best surgical strategy for anal fistula based on a network meta-analysis. Oncotarget 2017;8:99075-84. [PMID: 29228753 DOI: 10.18632/oncotarget.21836] [Cited by in Crossref: 9] [Cited by in F6Publishing: 4] [Article Influence: 1.8] [Reference Citation Analysis]
230 Gimble JM, Bunnell BA, Guilak F. Human adipose-derived cells: an update on the transition to clinical translation. Regen Med. 2012;7:225-235. [PMID: 22397611 DOI: 10.2217/rme.11.119] [Cited by in Crossref: 117] [Cited by in F6Publishing: 105] [Article Influence: 11.7] [Reference Citation Analysis]
231 Jongen J, Scheider J, Laubert T, Kahlke V. Plug, Laser, videogestützte Behandlung von Analfisteln, Over-The-Scope-Clip, Stammzellen: Reelle Alternativen zu den etablierten Therapien? coloproctology 2022;44:23-7. [DOI: 10.1007/s00053-021-00568-8] [Reference Citation Analysis]
232 Norderval S, Lundby L, Hougaard H, Buntzen S, Weum S, de Weerd L. Efficacy of autologous fat graft injection in the treatment of anovaginal fistulas. Tech Coloproctol. 2018;22:45-51. [PMID: 29285682 DOI: 10.1007/s10151-017-1739-0] [Cited by in Crossref: 17] [Cited by in F6Publishing: 12] [Article Influence: 3.4] [Reference Citation Analysis]
233 Ghazi LJ, Schwartz DA. Perianal Crohn's Disease—A Gastroenterologist's Perspective. Seminars in Colon and Rectal Surgery 2012;23:117-24. [DOI: 10.1053/j.scrs.2012.04.005] [Reference Citation Analysis]
234 Ordás I, Salas A, Benítez D, Ricart E, Panés J. [Rationale for cell therapy in the treatment of inflammatory bowel disease]. Gastroenterol Hepatol 2010;33:716-20. [PMID: 20381204 DOI: 10.1016/j.gastrohep.2010.01.003] [Reference Citation Analysis]
235 Meyer J, Ris F, Parkes M, Davies J. Rectovaginal Fistula in Crohn's Disease: When and How to Operate? Clin Colon Rectal Surg 2022;35:010-20. [DOI: 10.1055/s-0041-1740029] [Reference Citation Analysis]
236 Al-Maawali AK, Nguyen P, Phang PT. Modern Treatments and Stem Cell Therapies for Perianal Crohn's Fistulas. Can J Gastroenterol Hepatol 2016;2016:1651570. [PMID: 28053967 DOI: 10.1155/2016/1651570] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 1.7] [Reference Citation Analysis]
237 Földes A, Kádár K, Kerémi B, Zsembery Á, Gyires K, S Zádori Z, Varga G. Mesenchymal Stem Cells of Dental Origin-Their Potential for Antiinflammatory and Regenerative Actions in Brain and Gut Damage. Curr Neuropharmacol 2016;14:914-34. [PMID: 26791480 DOI: 10.2174/1570159x14666160121115210] [Cited by in Crossref: 16] [Cited by in F6Publishing: 11] [Article Influence: 3.2] [Reference Citation Analysis]
238 Sugrue J, Nordenstam J, Abcarian H, Bartholomew A, Schwartz JL, Mellgren A, Tozer PJ. Pathogenesis and persistence of cryptoglandular anal fistula: a systematic review. Tech Coloproctol 2017;21:425-32. [PMID: 28620877 DOI: 10.1007/s10151-017-1645-5] [Cited by in Crossref: 22] [Cited by in F6Publishing: 17] [Article Influence: 4.4] [Reference Citation Analysis]
239 Garg P, Yagnik VD, Dawka S, Kaur B, Menon GR. Guidelines to diagnose and treat peri-levator high-5 anal fistulas: Supralevator, suprasphincteric, extrasphincteric, high outersphincteric, and high intrarectal fistulas. World J Gastroenterol 2022; 28(16): 1608-1624 [DOI: 10.3748/wjg.v28.i16.1608] [Reference Citation Analysis]
240 Li Y, Altemus J, Lightner AL. Mesenchymal stem cells and acellular products attenuate murine induced colitis. Stem Cell Res Ther 2020;11:515. [PMID: 33256827 DOI: 10.1186/s13287-020-02025-7] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
241 Manieri NA, Mack MR, Himmelrich MD, Worthley DL, Hanson EM, Eckmann L, Wang TC, Stappenbeck TS. Mucosally transplanted mesenchymal stem cells stimulate intestinal healing by promoting angiogenesis. J Clin Invest 2015;125:3606-18. [PMID: 26280574 DOI: 10.1172/JCI81423] [Cited by in Crossref: 37] [Cited by in F6Publishing: 25] [Article Influence: 5.3] [Reference Citation Analysis]
242 Cho YB, Park KJ, Yoon SN, Song KH, Kim DS, Jung SH, Kim M, Jeong HY, Yu CS. Long-term results of adipose-derived stem cell therapy for the treatment of Crohn’s fistula. Stem Cells Transl Med. 2015;4:532-537. [PMID: 25829404 DOI: 10.5966/sctm.2014-0199] [Cited by in Crossref: 101] [Cited by in F6Publishing: 89] [Article Influence: 14.4] [Reference Citation Analysis]
243 Hanson S, Thibeault SL, Hematti P. Clinical applications of mesenchymal stem cells in laryngotracheal reconstruction. Curr Stem Cell Res Ther 2010;5:268-72. [PMID: 19951250 DOI: 10.2174/157488810791824449] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 0.8] [Reference Citation Analysis]
244 Moniuszko A, Sarnowska A, Rogowski W, Durlik M, Wluka A, Rydzewska G. Successful treatment of an enterovesical fistula due to Crohn's disease with stem cell transplantation: a case report. Prz Gastroenterol 2018;13:332-6. [PMID: 30581508 DOI: 10.5114/pg.2018.79814] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
245 Salem GA, Selby GB. Stem cell transplant in inflammatory bowel disease: a promising modality of treatment for a complicated disease course. Stem Cell Investig 2017;4:95. [PMID: 29270421 DOI: 10.21037/sci.2017.11.04] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 2.2] [Reference Citation Analysis]
246 Voswinkel J, Francois S, Simon JM, Benderitter M, Gorin NC, Mohty M, Fouillard L, Chapel A. Use of mesenchymal stem cells (MSC) in chronic inflammatory fistulizing and fibrotic diseases: a comprehensive review. Clin Rev Allergy Immunol 2013;45:180-92. [PMID: 23296948 DOI: 10.1007/s12016-012-8347-6] [Cited by in Crossref: 82] [Cited by in F6Publishing: 80] [Article Influence: 10.3] [Reference Citation Analysis]
247 Zeng G, Lai K, Li J, Zou Y, Huang H, Liang J, Tang X, Wei J, Zhang P. A rapid and efficient method for primary culture of human adipose-derived stem cells. Organogenesis 2013;9:287-95. [PMID: 24280895 DOI: 10.4161/org.27153] [Cited by in Crossref: 34] [Cited by in F6Publishing: 31] [Article Influence: 3.8] [Reference Citation Analysis]
248 Guo X, Li S, Ji Q, Lian R, Chen J. Enhanced viability and neural differential potential in poor post-thaw hADSCs by agarose multi-well dishes and spheroid culture. Hum Cell 2015;28:175-89. [PMID: 26054839 DOI: 10.1007/s13577-015-0116-4] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 1.9] [Reference Citation Analysis]
249 Zeng L, Yu G, Yang K, Xiang W, Li J, Chen H, Mishra R. Efficacy and Safety of Mesenchymal Stem Cell Transplantation in the Treatment of Autoimmune Diseases (Rheumatoid Arthritis, Systemic Lupus Erythematosus, Inflammatory Bowel Disease, Multiple Sclerosis, and Ankylosing Spondylitis): A Systematic Review and Meta-Analysis of Randomized Controlled Trial. Stem Cells International 2022;2022:1-20. [DOI: 10.1155/2022/9463314] [Reference Citation Analysis]
250 Lightner AL. Stem Cell Therapies for Inflammatory Bowel Disease. Curr Gastroenterol Rep 2019;21:16. [PMID: 30955111 DOI: 10.1007/s11894-019-0672-y] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
251 Marinaro F, Silva JM, Barros AA, Aroso IM, Gómez-blanco JC, Jardin I, Lopez JJ, Pulido M, de Pedro MÁ, Reis RL, Sánchez-margallo FM, Casado JG, López E. A Fibrin Coating Method of Polypropylene Meshes Enables the Adhesion of Menstrual Blood-Derived Mesenchymal Stromal Cells: A New Delivery Strategy for Stem Cell-Based Therapies. IJMS 2021;22:13385. [DOI: 10.3390/ijms222413385] [Reference Citation Analysis]
252 Flores AI, Gómez-Gómez GJ, Masedo-González Á, Martínez-Montiel MP. Stem cell therapy in inflammatory bowel disease: A promising therapeutic strategy? World J Stem Cells 2015;7:343-51. [PMID: 25815119 DOI: 10.4252/wjsc.v7.i2.343] [Cited by in Crossref: 23] [Cited by in F6Publishing: 22] [Article Influence: 3.3] [Reference Citation Analysis]
253 Tozer P, Borowski DW, Gupta A, Yassin N, Phillips R, Hart A. Managing perianal Crohn's fistula in the anti-TNFα era. Tech Coloproctol 2015;19:673-8. [PMID: 26264168 DOI: 10.1007/s10151-015-1332-3] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.7] [Reference Citation Analysis]
254 García-Olmo D, Herreros D, De-La-Quintana P, Guadalajara H, Trébol J, Georgiev-Hristov T, García-Arranz M. Adipose-derived stem cells in Crohn’s rectovaginal fistula. Case Rep Med. 2010;2010:961758. [PMID: 20224798 DOI: 10.1155/2010/961758] [Cited by in Crossref: 55] [Cited by in F6Publishing: 45] [Article Influence: 4.6] [Reference Citation Analysis]
255 Baik SH, Kim WH. A comprehensive review of inflammatory bowel disease focusing on surgical management. J Korean Soc Coloproctol 2012;28:121-31. [PMID: 22816055 DOI: 10.3393/jksc.2012.28.3.121] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
256 Al-toma A, Nijeboer P, Bouma G, Visser O, Mulder CJ. Hematopoietic stem cell transplantation for non-malignant gastrointestinal diseases. World J Gastroenterol 2014;20:17368-75. [PMID: 25516648 DOI: 10.3748/wjg.v20.i46.17368] [Reference Citation Analysis]
257 Roemeling-van Rhijn M, Mensah FK, Korevaar SS, Leijs MJ, van Osch GJ, Ijzermans JN, Betjes MG, Baan CC, Weimar W, Hoogduijn MJ. Effects of Hypoxia on the Immunomodulatory Properties of Adipose Tissue-Derived Mesenchymal Stem cells. Front Immunol 2013;4:203. [PMID: 23882269 DOI: 10.3389/fimmu.2013.00203] [Cited by in Crossref: 66] [Cited by in F6Publishing: 64] [Article Influence: 7.3] [Reference Citation Analysis]
258 Melmed GY, Targan SR. Future biologic targets for IBD: potentials and pitfalls. Nat Rev Gastroenterol Hepatol. 2010;7:110-117. [PMID: 20134493 DOI: 10.1038/nrgastro.2009.218] [Cited by in Crossref: 58] [Cited by in F6Publishing: 55] [Article Influence: 4.8] [Reference Citation Analysis]
259 Linard C, Busson E, Holler V, Strup-Perrot C, Lacave-Lapalun JV, Lhomme B, Prat M, Devauchelle P, Sabourin JC, Simon JM, Bonneau M, Lataillade JJ, Benderitter M. Repeated autologous bone marrow-derived mesenchymal stem cell injections improve radiation-induced proctitis in pigs. Stem Cells Transl Med 2013;2:916-27. [PMID: 24068742 DOI: 10.5966/sctm.2013-0030] [Cited by in Crossref: 66] [Cited by in F6Publishing: 60] [Article Influence: 7.3] [Reference Citation Analysis]
260 Sarveazad A, Newstead GL, Mirzaei R, Joghataei MT, Bakhtiari M, Babahajian A, Mahjoubi B. A new method for treating fecal incontinence by implanting stem cells derived from human adipose tissue: preliminary findings of a randomized double-blind clinical trial. Stem Cell Res Ther. 2017;8:40. [PMID: 28222801 DOI: 10.1186/s13287-017-0489-2] [Cited by in Crossref: 27] [Cited by in F6Publishing: 22] [Article Influence: 5.4] [Reference Citation Analysis]